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1.1 Chronic stress as a risk factor 
The daily life of people living in western societies seems to become more and more 
stressful, which results in a dramatic increase of incidences of stress-associated diseases. 
Chronic work stress has been described to increase the risk to develop metabolic syndrome 
(Chandola et al., 2006) and stress is also associated with cardiovascular disease. Strong 
epidemiological evidence supports a significant role of psychosocial stress in the 
development of coronary heart disease (Holmes et al., 2006; Brydon et al., 2006; Strike and 
Steptoe, 2004; Rozanski et al., 2005) and chronic stress largely increases the risk of a fatal 
stroke in older men (Ohlin et al., 2004). Many psychiatric diseases are also associated with 
high levels of stress. For example, strong psychosocial stress has been reported to increase 
the risk to develop Alzheimer's disease a twofold (Wilson et al., 2003). Major depression, 
which is one of the most common mental disorders worldwide and is predicted by the 
World Health Organization to be the leading cause of disability by 2020, can be caused or 
facilitated by chronic stress exposure. Work stress has also been correlated with an 
increased risk for depression (Wang et al., 2005) and stress has been shown to accelerate 
disease processes and cause neuronal degeneration (Gold et al., 1988; Nestler et al., 2002; 
Tafet and Bernardini, 2003). The notion that chronic stress exposure could be causal for the 
development of affective disorders is supported by findings of altered hypothalamic-
pituitary-adrenal axis function (Holsboer, 2000; Ising et al., 2007) and increased 
corticotropin releasing hormone levels in depressed patients, which is ameliorated by 
antidepressant treatment (Nemeroff et al., 1984; De Bellis et al., 1993).  
However, many authors have also pointed out that stress per se is in most cases not 
sufficient to cause disease. Not all people become ill after serious, long-lasting stressful 
experiences. Others develop a disease after having experienced stress which was 
comparably mild. Stress also constitutes a risk factor for many diverse diseases and every 
individual seems to be affected in a different way. Kendler and colleagues hypothesized 
that genetic factors influence the risk of a manifestation of major depression partly by 
altering the sensitivity of individuals to the depression-inducing effect of stressful life 
events (Kendler et al., 1995). This emphasizes the urgency to identify genetic or epigenetic 
factors, which determine the vulnerability of an individual to stressful life events. This 
issue can only partly be answered by epidemiological studies, as non-experimental studies 
in human patient populations always face major methodological problems, including the 
general inaccuracy of life event reporting and dating (Kessler, 1997). It is therefore 
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inevitable to adjoin data from epidemiological studies with results from several preclinical 
approaches using animal models. 
 
1.2 Animal models for chronic stress 
Animal models for human diseases are rated according to three different criteria: face 
validity, predictive validity and construct validity (Willner, 1984; Willner and Mitchell, 
2002). Face validity means that the phenotype created by the model should be highly 
similar to the human disease characteristics and replicate a number of the specific 
symptoms. This criterion can only be accomplished for a subset of disease characteristics, 
like the neuroendocrine, physiological or behavioural phenotype. Other disease 
characteristics, like suicidal behaviour of depressed patients, are often impossible to mimic 
in animals. Predictive validity describes whether drugs, which have been shown to be 
specific and effective in humans, can pharmacologically manipulate the disease phenotype. 
This validity criterion is facing the problem, that there may be no specific and effective 
drugs for the disease available. In the case of antidepressants, all available drugs suffer 
from a high non-responder rate and a late onset of therapeutic efficacy. Finally, the term 
construct validity implies that the etiology of the disease in the model is homologous and is 
based on an empirical and theoretical relationship to the disorder it models. This validity 
criterion is probably the hardest criterion to fulfil for an animal model, as the "construct" of 
the disease is often still unclear and the object of investigation. However, if for instance 
specific risk factors have been identified for a disease, they should be implemented in a 
potential animal model. Although it is hard to completely meet all of these three criteria, 
there are a number of good and validated animal models for chronic stress.  
Among the most commonly used animals for chronic stress research are rodents and non-
human primates. Especially the latter are often used to model diseases, which are likely to 
be specific to animals with higher brain development (like e.g. depression). The obvious 
advantage of non-human primates is their close relationship to humans. Their brains share 
structural and functional features with the human brain and non-human primates display 
many similar behavioural domains. With these animals it seems most likely that complex 
diseases like depression can be mimicked. Primate models almost exclusively use social 
stressors and have generally focused on phenotypes of psychiatric diseases. The social 
stressor is often based on maternal separation paradigms (Rosenblum and Paully, 1987; 
Gilmer and McKinney, 2003). Harlow and Suomi have pioneered this work by using 
maternal separation paradigms in rhesus monkeys to induce depression-like symptoms in 
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the offspring (Harlow and Suomi, 1971; Harlow and Suomi, 1974). Besides face and 
construct validity, these models also have shown predictive validity, as the effects could be 
reversed by antidepressant treatment (Suomi et al., 1978). Another very interesting non-
rodent animal model for depression-like symptoms is the tree shrew. First developed by 
von Holst and colleagues (Von Holst, 1977), male tree shrews are subjected to chronic 
social defeat stress over a time period of 24 days. Defeated animals show clear symptoms 
resembling a depression-like state, which can be ameliorated by antidepressant treatment 
(Meyer et al., 2001). However, the main obstacle with primate studies remains the low 
availability of test animals due to the high maintenance costs and the obviously involved 
ethical issues.  
To avoid these limitations, rodent models have become a widely accepted alternative to 
study disease mechanisms for chronic stress. In the past decades, numerous animal models 
for chronic stress in rodents have been developed. Based on the assumption that chronic 
stress related diseases are based on elevated levels of glucocorticoids, paradigms of chronic 
stress often apply physical stressors as repeated restraint or immobilisation stress (Kim and 
Han, 2006; Sabban et al., 2006). In order to avoid adaptation and predictability of a 
repeated exposure to the same stimulus, Willner et al. developed the chronic mild stress 
paradigm (CMS). This nowadays widely used and accepted paradigm for chronic stress in 
rats or mice utilizes a wide variety of mild physical stressors such as cold, food deprivation, 
cage tilt or changes in the dark/light cycle with a daily variation of the stressful stimulus 
(Willner et al., 1987). The phenotype of animals submitted to CMS indeed resembles 
aspects of depression in many features, including anhedonia (a loss of interest in 
pleasurable activities), increased immobility in the forced swim test, decreased sexual 
behaviour, decreased grooming and decreased REM sleep (Willner, 2005). One of the 
oldest and most widely used animal models is the learned helplessness model (Seligman 
and Beagley, 1975; Seligman and Beagley, 1975), where the animals are exposed to 
aversive stimuli, which they can not predict, control or avoid leading to deficits in escape 
performance, called learned helplessness. Additionally symptoms like loss of appetite and 
weight as well as a decrease in motor activity occur, resembling those of depressed patients. 
The kind of stressor used is very critical, though, as different stressors activate different 
neuronal circuits (Herman and Cullinan, 1997) and marked differences in reactions to 
physical compared to psychological stressors have been observed.  
In humans, the most common stressors reported as risk factors for stress-induced diseases 
are of social nature (Brown and Prudo, 1981). To increase the construct validity in terms of 
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the nature of the stressor, other rodent models are based on social stressors. Social stress is 
probably one of the most pervasive stressors in humans and social animals (Sachser et al., 
1998; Bartolomucci et al., 2005; Fuchs, 2005). Animals exposed to inescapable social stress 
situations for a long time show extreme increases of their hypothalamic-pituitary-adrenal 
(HPA) system activity and a high mortality rate (Fuchs and Flugge, 2003). The most 
commonly used experimental paradigms for social stress are the chronic social defeat 
paradigm, where the animals are repeatedly and continuously confronted with a larger and 
aggressive resident mouse (for review: Koolhaas et al., 1997a), the visible burrow system, 
where in mixed-sex rat groups maintained in a habitat providing burrows and an open area, 
offensive and defensive behaviors of males are associated with the development of 
dominance hierarchies (Blanchard et al., 1995; Albeck et al., 1997) or other forms of social 
instability (Ahima et al., 1998; Ader, 1969; Kudryavtseva, 2000). All of these models show 
a high degree of face and predictive validity. However, a major drawback of these 
paradigms is that they are relatively work intensive and space consuming so that only a few 
animals per group can be tested in a specific experiment. This is of particular importance in 
view of individual differences in the susceptibility to chronic stress and stress-induced 
pathologies due to genetic or epigenetic variability. The possibility to examine individual 
variations within a treatment group, to identify vulnerable and resistant animals and to 
examine long-lasting changes of the stress experience is thus largely restricted with these 
paradigms. Another important issue that needs to be addressed when regarding face validity 
is the persistence of symptoms resulting from chronic stress exposure. The majority of 
studies investigated only effects during or right after cessation of the stressor, thereby 
concentrating mainly on acute effects. However, in humans the maladaptive responses to 
chronic stress often outlast the actual stress phase by many years or even decades. Only few 
preclinical studies assessed potential long-term effects of acute or chronic stressors and 
only a small number of studies have pointed out that some of the observed neuroendocrine 
and behavioral effects evoked by chronic stressors persist after the stress is discontinued, 
which is a crucial factor with respect to human pathology (Tsankova et al., 2006). 
 
1.3 Hypothalamo pituitary adrenal axis regulation 
Every threat to the body, no matter if real or imagined, acts as a stressor and evokes a stress 
response. This serves to restore homeostasis, a dynamic equilibrium that is strived to be 
maintained by all living organisms. The process of reestablishing homeostasis in the face of 
a challenge was termed allostasis (Sterling and Eyer, 1981). It means that stability is 
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achieved through change, in part by the process of increasing sympathetic and hypothalamo 
pituitary adrenal (HPA) activity. Thereby mediators such as adrenaline and cortisol are 
released, which promote adaptation (McEwen and Stellar, 1993; Sterling and Eyer J, 1988). 
Hence, a brief period of controllable stress is rather beneficial to health. In contrast, lack of 
control and uncertainty can produce a chronic state of hyper activation of the stress axis 
where the stress mediators are not turned off adequately. In case of an inadequate or 
extremely prolonged stress response, where the allostatic systems remain active over a long 
period of time, the costs of reinstating homeostasis might be too high. This condition is 
termed allostatic load or overload (McEwen and Stellar, 1993; McEwen, 1997; Schulkin et 
al., 1994) and is generally considered to enhance vulnerability to disease. Allostatic load 
leads for instance to impaired immunity, atherosclerosis, obesity, bone demineralization 
and atrophy of nerve cells in the brain. Many of these processes are seen in major 
depression and in anxiety disorders (for review see: McEwen, 2004).   
Essential to the stress response is, besides the activation of the fast sympathico 
adrenomedullary system driving the ‘fight or flight’ response, the activation of the 
hypothalamo pituitary adrenal axis, which is more persistent in its actions (for review: de 
Kloet et al., 2005). When the parvocellular neurons in the paraventricular nucleus (PVN) of 
the hypothalamus are stimulated, they secrete the peptides corticotropin releasing hormone 
(CRH) and vasopressin (AVP), which are stored at the nerve terminals in the median 
eminence, into a portal vessel system that links the median eminence with the anterior part 
of the pituitary. There they bind to their respective receptors (CRHR1 and V1b) and 
activate the synthesis of pro-opiomelanocortin (POMC), which is then further processed to 
corticotropin (ACTH), opioid and melanocortin peptides, among others. CRH is thought to 
be the main activator of ACTH release, but AVP, which is co-expressed and co-secreted 
mainly after prolonged stress periods, can amplify the effects. ACTH is released in the 
blood stream and stimulates via binding to its specific receptors in the adrenal cortex the 
secretion of cortisol (in humans) and corticosterone (in humans and rodents). Circulating 
glucocorticoids can reach every organ of the body, thereby contributing to recovery and 
adaptation. In the periphery they exert their functions mainly via mobilizing energy 
resources, dampening of immune reactions and increasing the vascular tone (Munck and 
Naray-Fejes-Toth, 1992). Further, they prevent stress responses from overshooting by 
affecting specific afferent pathways involved in activating the PVN, such as for example 
the prefrontal cortex, the hippocampus, nuclei of the brain stem or the amygdala, altogether 
leading to a reduced HPA axis activity. In addition, glucocorticoids exert a direct negative 
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feedback at different levels of the HPA axis like the PVN and the pituitary, thereby leading 
to a normalization of HPA axis function.  
 
Figure 1: Schematic overview of the 
hypothalamic-pituitary-adrenal axis (HPA axis) in 
the neuroendocrine stress response. Activation of 
the paraventricular nucleus (PVN) of the 
hypothalamus by the brainstem and higher brain 
areas initiates the release of corticotropin-
releasing hormone (CRH) and arginine 
vasopressin (AVP) at the level of the median 
eminence into the hypophysial portal vessels. At 
the anterior lobe of the pituitary CRH and AVP 
act synergistically to release adrenocorticotropic 
hormone (ACTH) into the blood stream. ACTH, 
in turn, stimulates the secretion of glucocorticoids 
from the fasciculate zone of the adrenal cortex. 
Corticosteroids feed back to the HPA system by 
binding to the glucocorticoid (GR) and 
mineralocorticoid (MR) receptors in the brain and 
the pituitary to restrain the activity of the HPA 
axis and restore homeostasis. 
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Glucocorticoids bind to two related receptors in the brain, the mineralocorticoid receptors 
(MRs) and the glucocorticoid receptors (GRs), albeit with a different affinity. MRs bind 
corticosterone with a tenfold higher affinity compared to GRs (Reul and de Kloet, 1985; 
Arriza et al., 1988) and are largely saturated at low basal corticosterone levels. GRs are 
additionally activated when corticosterone levels are high, i.e. at the circadian peak or after 
stressful events. Therefore MRs are implicated in the maintenance of basal activity of the 
stress system by proactive feedback, while GRs are rather involved in the termination of the 
stress induced HPA activation by reactive feedback (for review: de Kloet et al., 1998). MRs 
and GRs have also a distinctly different distribution throughout the brain: MRs are 
predominantly present in the limbic system with a very dense expression in the 
hippocampus, whereas GRs are ubiquitously expressed but are most abundant in the 
hippocampus, hypothalamic CRH neurons and pituitary corticotropes. Co-expression is 
therefore restricted to a few distinct areas of the limbic system with the hippocampus being 
the most relevant region. Both receptor types are cytosolic receptors that, upon binding of 
their ligand, translocate to the nucleus and bind as homo- or -in regions of coexistence of 
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GR and MR- also as heterodimers to a consensus sequence of the DNA, the glucocorticoid 
response elements (GRE). Thereby they recruit either co-activators or co-repressors, 
leading to either activation or repression of gene expression (Meijer et al., 2005). As 
monomers GRs can also directly interact with transcription factors like NFκB, AP-1 or 
CREB, thereby leading to a reduction of their transcriptional activity (de Kloet et al., 2005). 
In addition to the genomic actions of these receptors, MRs have recently been implicated in 
fast, non-genomic glucocorticoid actions. These pathways are likely to involve MRs 
inserted into the plasma membrane, which emerge with high corticosteroid concentrations 
that occur after stress exposure. Therefore the MRs probably shuttle from the cytoplasm to 
the cell membrane and, following ligand binding, enhance glutamate transmission. Through 
the fast non genomic and the delayed genomic effects, corticosterone can alter hippocampal 
activity over a very long period of time during and after experience of a stressful situation 
(Karst et al., 2005). 
Additionally, GRs and MRs have been implicated in the regulation of anxiety related 
behavior (Gass et al., 2001) and are involved in specific aspects of information processing 
such as in the modulation of learning and memory (Oitzl and de Kloet, 1992; Sandi and 
Rose, 1994; Tronche et al., 1999; Oitzl et al., 2001). Thereby MRs seem to play a role in 
the behavioral reactivity during novel situations, while GRs are more important for 
information storage and consolidation (Oitzl et al., 1994; Oitzl et al., 1997; Akagi et al., 
1997; Shors, 2001).  
The balance between MRs mediating the maintenance of homeostasis and GRs promoting 
recovery is therefore very critical for the effects glucocorticoids exert on the brain, leading 
to a specific tone of HPA axis feedback control (de Kloet, 2003).  
In conclusion, the stress response, when activated for a short time, provides the body a fast 
and efficient way to mobilize energy and to pass through a stressful situation. A prolonged 
state of hyper activation accompanied by the resulting chronically elevated glucocorticoid 
levels, though, is maladaptive, rather damaging to the body and is considered to enhance 
disease vulnerability.  
 
1.4 Scope of the thesis 
In avoidance of the before mentioned limitations, a novel mouse paradigm for chronic 
social stress was developed. In contrast to previous animal models of social stress, which 
are often based on the differentiation of dominant and subordinate animals (with the latter 
ones generally found as the more vulnerable animals), this paradigm is based on a complete 
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disruption of social hierarchy. In order to achieve this situation, the cage composition of 
male mice housed in groups of four is randomly changed twice per week for a period of 
seven weeks starting at postnatal day 28. This means, that every mouse in the paradigm is 
faced with three unknown mice every three to four days, which creates a highly unstable 
and unpredictable social environment for all mice. Control animals are also housed in 
groups of four, but remain with the same cage mates throughout the experiment and 
generally establish a stable hierarchy. At the end of the chronic stress phase all animals are 
separated and since then kept in single housing. This stress paradigm can be easily 
conducted with a high number of animals. 
 
In order to appraise the novel model, the following objectives were defined: 
(1) validation of the recently developed chronic social stress paradigm with regard to face, 
predictive and construct validity 
(2) investigation of potential persisting or long-term effects of chronic stress during 
adolescence on a physiological, neuroendocrine and behavioral level 
(3) investigation of a potential influence of the stress regimen during adolescence on 
learning and memory in aged animals  
(4) investigation of chronic stress during adolescence as a risk factor for metabolic 
alterations at older age 
(5) assessment of the potential efficacy of treatment with the cannabinoid receptor 1 
antagonist rimonabant in preventing consequences of chronic stress 
 
To pursue these objectives, the following experiments were conducted: 
In project 1 we characterized the physiological, neuroendocrine and behavioral alterations 
obtained 7-14 days after cessation of the stress regimen, i.e. after 7-14 days of recovery. 
Additionally, the efficacy of treating the animals during the stress phase chronically with 
either the serotonin reuptake inhibitor (SSRI) paroxetine or the corticotropin releasing 
hormone receptor 1 (CRHR1) antagonist DMP696 on preventing negative consequences 
evoked by the chronic social stress regimen is assessed. Project 2 characterizes persistent 
physiological, neuroendocrine and behavioral alterations obtained 12 months after stress 
termination in comparison to the immediate effects obtained at the end of the stress period. 
In project 3 we investigated the learning and memory performance of 15 months old 
animals (i.e. 12 months after cessation of the stressor) on a behavioral, electrophysiological 
and neurogenetic level. The experiment described in project 4 was performed to assess 
Introduction 
 16
metabolic alterations following chronic stress in aged animals. Therefore the body fat 
distribution of subcutaneous and visceral fat was determined in 12 months old mice using 
functional magnet resonance imaging In project 5 the impact of chronic rimonabant 
treatment during the chronic stress period on physiological, neuroendocrine and behavioral 
alterations observed in untreated stress animals is assessed 7-14 days after cessation of the 
stress regimen, i.e. after 7-14 days of recovery. To further characterize potential changes in 
metabolic parameters, at the age of six and twelve months, respectively, the animals were 
subjected to an oral glucose tolerance test and their glucose and corresponding insulin 
levels were measured. 
Due to the heterogeneity of the data each project will be introduced and discussed 
separately. 
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2.1 Animals and stress procedure 
Animals 
Experiments were carried out with male CD1 mice from the Charles River Laboratories 
(Maastricht, the Netherlands). The animals were 26-28 days old on the day of arrival. All 
animals were housed in groups of four per cage (45 x 25 x 20 cm) under a 12L:12D cycle 
(lights on at 6.00 h) and constant temperature (23 + 2 °C) conditions. Food and water were 
provided ad libitum. The experiments were performed at the animal facility of the Max 
Planck Institute of Psychiatry in Munich, Germany.  
The experiments were carried out in accordance with European Communities Council 
Directive 86/609/EEC. All efforts were made to minimize animal suffering during the 
experiments. The protocols were approved by the committee for the Care and Use of 
Laboratory Animals of the Government of Upper Bavaria, Germany. 
 
Chronic stress procedure 
The chronic stress procedure was performed during the adolescent and young adult period 
of the mice, between the age of 4 and 12 weeks. After a habituation period of 5 days 
following arrival, the group composition in each cage was changed twice per week for 7 
weeks so that four mice from different cages were put together in a new, clean cage. The 
rotation schedule was randomized to minimize the likelihood of a repeated encounter of the 
same mice throughout the experiment. Animals of the control group remained with the 
same cagemates throughout the experiment. After 7 weeks of chronic stress procedure, all 
mice (control and chronic stress) were separated and single housed for at least seven days 
before testing (cage size 45 x 25 x 20 cm). Although single housing represents a stressor in 
itself in many species, in male mice it has been shown that single housing does not affect 
main immuno-endocrine parameters under basal conditions (Bartolomucci et al., 2003b). 
Body weight was monitored every two weeks throughout the stress procedure. Animals 
with bites were excluded from the experiments (less than 2% of the animals in the chronic 
stress group).  
For the investigation of long-term consequences, all mice (control and chronic stress) were 
separated at the end of the stress procedure and since then kept in single housing (cage size 
45 x 25 x 20 cm) until conduction of the respective experiments. 
 
Material and methods 
 21
Determination of social status 
The social status and interactions of the animals in the chronic stress and in the control 
group were determined according to literature reports (Bartolomucci et al., 2004), with 
some adaptations. Each cage was observed soon after regrouping (stress animals) or cage 
change (control animals) for an observation period of 60 minutes. During this time 
measurements of aggression, grooming, resting and food intake were taken every 5 minutes 
for 1 minute (12 observation periods in total). The animal chasing and biting the other cage 
mates was identified as dominant.  
 
2.2 Drugs 
All drugs were applied via drinking water. Paroxetine was obtained from GlaxoSmithKline 
(Munich, Germany) as a solution and was diluted in tap water to a final concentration of 
0,16 mg/ml. With average water consumption of 5 ml/mouse/day, the daily dose of 
paroxetine was approximately 20 μg/g body weight. Fluid intake was monitored daily and 
the variation of fluid intake was found to be less than 10% over the course of the 
experiment, thereby ensuring the correct dosage of the drug. The CRHR1 antagonist 
DMP696 was donated by Bristol-Myers Squibb (New York, USA). The drug was dissolved 
in a 0,25% Methocel (Georg Breuer GmbH, Germany) solution at a stock concentration of 
16 mg/ml by bead milling it over night at 4 °C. The stock solution was then diluted with 
water to a final concentration of 0,16 mg/ml (approximately 20 μg/g body weight per day). 
The CB1 antagonist rimonabant (SR141716A) was donated by Sanofi-Aventis (Bagneux, 
France). The drug was dissolved in 100% EtOH by vortexing for 10 minutes and after 
adding of 1 ml water by bead milling 2 hours at room temperature (stock concentration of 
24 mg/ml). The stock solution was then further diluted with water to a final concentration 
of 0,08 mg/ml and applied via the drinking water. With average water consumption of 5 
ml/mouse/day, the daily dose of rimonabant was approximately 10 μg/g body weight. Fluid 
intake was monitored daily and the variation of fluid intake was found to be less than 10% 
over the course of the experiment, thereby ensuring the correct dosage of the drug.  
The respective dosages of paroxetine, DMP696 and rimonabant were based on literature 
reports (Keck et al., 2003; Li et al., 2003; Griebel et al., 2005). Drug solutions were 
replaced on a daily basis.  
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2.3 Sampling procedures  
Trunk or tail cut blood was collected individually in labeled 1.5 ml EDTA-coated 
microcentrifuge tubes (Kabe Labortechnik, Germany). The time between the first 
disturbance of the animals and the sampling was in all cases less than 1 minute. Tail blood 
was collected without anesthesia as described previously (Fluttert et al., 2000) by inflicting 
a small incision at the bottom of the mices’ tail using a racor blade. For trunk blood 
collection animals were anesthetized in isoflurane and decapitated. All blood samples were 
kept on ice and later centrifuged for 15 minutes at 6000 rpm at 4 °C. Plasma was 
transferred to clean, labeled 1.5 ml microcentrifuge tubes. All plasma samples were stored 
frozen at –20 °C. After decapitation, brains were removed, frozen in isopentane at –40 °C 
and stored a –80 °C for in-situ hybridization. Adrenal and thymus glands were removed, 
dissected from fat and weighed.  
 
2.4 Analytics 
In situ hybridization 
Frozen brains were sectioned at -20 °C in a cryostat microtome at 16 μm in the coronal 
plane through the level of the hypothalamic PVN and dorsal hippocampus. The sections 
were thaw-mounted on superfrost slides, dried and kept at -80 °C. In situ hybridization 
using 35S UTP labeled ribonucleotide probes (CRH, GR, MR, GluR1, α1GABA(A) and 
NMDA NR1) were performed as described previously (Schmidt et al., 2002). Briefly, for 
riboprobe in-situ hybridization sections were fixed in 4% paraformaldehyde and acetylated 
in 0.25% acetic anhydride in 0.1 M triethanolamine/HCl. Subsequently, brain sections were 
dehydrated in increasing concentrations of ethanol. The antisense cRNA probes for CRH, 
GR, MR, GluR1, α1GABA(A) and NMDA NR1 were transcribed from the respective 
linearized plasmid. Tissue sections were saturated with 100 μl of hybridization buffer 
containing approximately 1.5 x 106 cpm 35S labeled riboprobe. Brain sections were 
coverslipped and incubated overnight at 55 °C. The following day the sections were rinsed 
in 2 X SSC (standard saline citrate), treated with RNAse A (20 mg/l) and washed in 
increasingly stringent SSC solutions at room temperature. Finally sections were washed in 
0.1 X SSC for 1 hour at 65 °C and dehydrated through increasing concentrations of alcohol. 
For AVP and BDNF, oligo in-situ hybridizations were performed. The oligonucleotides 
(sequence: 5’ gggcttggcagaatccacggactcttgtgtcccagcc-gctgtaccag 3’ for AVP and 
5’agttccagtgccttttgtctatgcccctgcagccttccttggtgt3' for BDNF, respectively) were labeled with 
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35S dATP using terminal transferase (TdT, Boehringer, Ingelheim, Germany) and added to 
the hybridization mix. Brain sections were coverslipped and incubated overnight at 45 °C. 
The following day the sections were washed in 1 X SSC at 55 °C and dehydrated through 
increasing concentrations of alcohol. 
The slides were apposed to Kodak Biomax MR films (Eastman Kodak Co., Rochester, NY) 
and developed. Autoradiographs were digitized, and relative expression was determined by 
computer-assisted optical densitometry (Scion Image, Scion Corporation, Frederic, USA). 
The mean of 4 measurements of two different brain slices was calculated from each animal. 
The data were analyzed blindly, always subtracting the background signal of a nearby 
structure not expressing the gene of interest from the measurements. For AVP, slides were 
also dipped in Kodak NTB2 emulsion (Eastman Kodak Co., Rochester, USA) and exposed 
at 4 °C for 6 days. Slides were developed, counterstained with cresyl violet staining and 
examined with a light microscope with both bright and dark field condensers. 
 
Radio immuno assay 
For quantitative analysis of corticosterone and ACTH in plasma a commercial 
radioimmunoassay (RIA) kit (MP Biomedicals Inc. (Illkirch, France); sensitivity 6.25 
ng/ml and 10 pg/ml, respectively) was used according to the instructions of the 
manufacturer’s protocol. Corticosterone and ACTH were measured in the same animals.  
 
Western blot 
The hippocampus was homogenized in HEPES buffer containing 1% NP40 and several 
proteinase inhibitors (based on Hope et al., 1994), and centrifuged to eliminate cell debris. 
The supernatant was used as total protein sample. Protein concentration was determined 
with the BioRad DC protein kit (BioRad, München, Germany). 25 μg protein per lane were 
loaded on 9% SDS–PAGE and transferred to nitrocellulose (Protran BA85, 45 μm, 
Schleicher and Schüll, Dassel, Germany), using a Mini Transfer Cell (BioRad). The 
membranes were blocked with 5% BSA in TBS containing 0.1% Tween 20 (TBS-T) and 
incubated with the different primary antibodies overnight. The following antibodies were 
used for Western blot analysis: NMDAR2B (Chemicon, Upstate), GluR1 (AB06-306 
Upstate) and α1-GABAA (AB06-868, Upstate). Incubation with the secondary antibody 
(horseradish peroxidase-conjugated donkey anti-rabbit antibody, Amersham Buchler, 
Braunschweig, Germany) lasted 2 hours. All antibody incubations, washes and dilutions 
were performed in TBS-T. Antibody detection was performed with Amersham ECL 
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Western blotting analysis system according to the manufacturer’s protocol. ECL signal was 
exposed to Hyperfilm-ECL (Amersham Buchler). For control of protein amounts, samples 
(25 μg) were run on a 9% SDS–PAGE and the gels were stained with Coomassie Brilliant 
Blue. One gel was stained with Coomassie Blue and used to normalize the data and ensure 
equal loading on each well of the gel. To check for efficacy of protein transfer from the gel 
and to match Coomassie-stained bands with the respective protein levels, reversible 
staining of the membrane was also done with Ponceau S after transfer to ensure 
homogeneity of transfer. The data were normalized to the amount of protein loaded in each 
lane of the Coomassie Blue stained gel that was run in parallel by measuring the intensity 
of the whole lane. 
Unless otherwise stated all chemicals were obtained from Sigma (Deisenhofen, Germany). 
At least 3 blots were prepared per antibody which were analyzed and averaged. Each 
Western blot comprised the control and the remaining experimental group. Blot 
autoradiographs were quantified by computer-assisted densitometry using the Optimas 
image analysis system (Optimas/BioScan, Edmonds, USA). All data are expressed as 
relative grey values and the values for the different groups were determined by setting the 
control group to 100% and calculating the relative percentages of the other groups. The data 
for the different groups were normalized to the amount of protein loaded in each lane in the 
Coomassie blue-stained gel that was run in parallel. 
 
2.5 Behavioral tests 
All behavioral tests were performed between 8.00 and 12.00h in the room where the 
animals were housed. 
 
Open field test 
 Open field arenas (50 x 50 x 50 cm) were made of gray PVC and evenly illuminated 
during testing (20 lux). General locomotor activity was recorded for 30 minutes (distance 
traveled) using a video-tracking system (Anymaze 4.20, Stoelting, Illinois, USA). The 
locomotor activity of the first and the fifth minute of open field exposure were subtracted to 
calculate the locomotor adaptation in the novel environment as a measure of anxiety. A 
high degree of locomotor adaptation indicates low anxiety, while a low degree of locomotor 
adaptation indicates high anxiety. The last 20 minutes of the open field test were used to 
assess differences in general locomotor activity between the groups. 
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Novelty-induced suppression of feeding paradigm 
The test was performed according to Merali et al. with some adaptations (Merali et al., 
2003). 3 days before testing the animals received an almond sliver in a small plastic dish in 
their home cage for 2 consecutive days. The consumption time of the almond in the home 
cage environment was less than 30 seconds for all mice on the second day, with no 
differences between the groups. Testing was performed in an open field arena as described 
above, with a plastic dish in the center containing a small piece of almond. The animals 
were familiar with both the dish and the almond, but were unfamiliar with the open field 
arena. The latency until the initiation of food intake was recorded. The total test time was 
30 minutes. Shorter consumption times were interpreted as lower anxiety levels. 
 
Elevated Plus maze 
The elevated plus maze consisted of two opposing open arms (30 x 5 x 0,5 cm) and two 
opposing enclosed arms (30 x 5 x 15 cm) of gray PVC, which were connected by a central 
platform (5 x 5 cm) shaping a plus sign. Animals were placed in the center of the plus maze 
and were allowed to explore it for 5 minutes. Percent of time spent in the open arms and 
percent entries to the open arms were recorded, as well as head dips (Rodgers and Dalvi, 
1997; Müller et al., 2003).  
 
Y-maze  
The Y-maze was made of grey PVC and consisted of three arms with an angle of 120° 
between each of the two arms differentially marked by tape symbols (triangles, bars and 
plus-signs, respectively). The arms were 30 x 10 x 15 cm (l x w x h) each and evenly 
illuminated during testing (40 lux). The Y-maze test comprises two trials separated by an 
intertrial interval (ITI) to assess spatial recognition memory. During the first trial, the 
acquisition phase, the mouse was allowed to explore two of the three arms for 5 minutes 
while the third arm was blocked. After an ITI of 1 hour the second trial, the retrieval phase, 
was conducted during which all three arms were accessible for 5 minutes. The percentage 
time spent in the novel arm compared to the known arms was scored using a video-tracking 
system (Anymaze 4.20, Stoelting, USA) with a significantly higher percentage than chance 
level (>33,3 %) being rated as successful spatial memory. 
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Social discrimination task 
The test was performed according to Engelmann et al. with some adaptations (Engelmann 
et al., 1995). All test animals were habituated to the experimental cages for 40 minutes 
followed by a 5-minute presentation of an ovarectomized female, which was placed into the 
cage immovable in a perforated plastic tube. After an intertrial interval of 1 hour, the first, 
familiar female was reintroduced to the male test mouse together with a novel, unfamiliar 
female. The time spent for olfactory investigation of the novel stimulus-female compared to 
the familiar one was observed. Olfactory investigation time of the unfamiliar female was 
taken as a parameter for the animals’ social memory. 
 
Object recognition test  
Testing was performed in an open field box (50 x 50 x 50 cm) under moderate illumination 
(30 lux). The test consisted of two phases, the sample phase and the trial phase. After 
habituation of 15 minutes, where the animals were allowed to become familiar with the 
empty arena, the test subjects were presented a glass object (e.g. a salt shaker) which they 
could freely explore for 5 minutes (sample phase). After an intertrial interval of 1 hour, 
where the mice were returned to their home cages, they were again placed into the arena 
and presented two different objects, the familiar glass one and a novel metal one, similar in 
size. To avoid influences of spatial memory, the location of the objects was changed 
between sample and trial phase. The percentage of the number and the duration exploring 
the unknown object compared to the known object was calculated, with a higher preference 
for the novel object being rated as intact recognition memory. 
 
Morris water maze 
The test was performed according to Morris with some adaptations for mice (Morris, 1984). 
Briefly, a circular pool (80 cm in diameter) was filled with 26 + 1 °C water that was made 
opaque by addition of chalk. A white painted platform (9 cm in diameter) was placed inside 
the pool 1 cm above the surface (visual training) or 1 cm below the surface of the water 
(spatial training). Several extra-maze visual cues were attached to the walls of the 
experimental room, approximately in a distance of 50-100 cm from the pool. After 1 day of 
a free swim trail, the 3 following days the mice were put on the platform for 1 minute each 
(pre-training). On day 5 they had to swim, locate the visible platform and climb onto it 
(visual training). In the spatial training phase the animals had to perform 4 trials each day 
on 3 consecutive days (day 8-10), where the now non-visible platform remained in a 
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constant position over the trials and days. The latency to reaching the platform as well as 
the total distance traveled was analyzed using a video-tracking system (Anymaze 4.30, 
Stoelting, USA). 
 
2.6 Electrophysiology 
Transverse hippocampal slices (350 μm) were obtained from the brains of adult, 15-month-
old mice, that were anesthetized with isoflurane and then decapitated. The brain was rapidly 
removed, and slices were prepared in icy Ringer solution using a vibroslicer. All slices 
were placed in a holding chamber for at least 60 minutes and were then transferred to a 
superfusing chamber for extra cellular or whole-cell recordings. The flow rate of the 
solution through the chamber was 1,5 ml/min. The composition of the solution was 124 
mM NaCl, 3 mM KCl, 26 mM NaHCO3, 2 mM CaCl2, 1 mM MgSO4, 10 mM D-glucose, 
and 1,25 mM NaH2PO4, bubbled with a 95% O2–5% CO2 mixture, and had a final pH of 
7,3. All experiments were performed at room temperature. 
Extra cellular recordings of field excitatory postsynaptic potentials (fEPSPs) were obtained 
from the dendritic region of the CA1 region of the hippocampus using glass micropipettes 
(1–2 MΩ) filled with superfusion solution. For LTP induction, high-frequency stimulation 
conditioning pulses (100 Hz/1 s) were applied to the Schaffer collateral-commissural 
pathway. Measurements of the slope of the fEPSP were taken between 20 and 80% of the 
peak amplitude. Slopes of fEPSPs were normalized with respect to the 20-min control 
period before tetanic stimulation. 
fEPSPs were evoked by stimuli (0.033Hz, 4–5 V, 20 µs), delivered via two bipolar tungsten 
electrodes insulated to the tip (5-µm tip diameter) and positioned in the Schaffer collateral–
commissural pathway. The recordings were amplified, filtered (3 kHz) and digitized (9 
kHz). The digitized responses were stored to disk using a data acquisition program. 
Stimulation, recording and analysis of excitatory postsynaptic potentials and LTP in the 
CA1 region of the hippocampus were performed as described previously (Simon et al., 
2001).  
 
2.7 Magnet resonance imaging 
To assess intra abdominal fat distribution we applied magnetic resonance imaging. The 
animals were measured ex-vivo on a 7 T BRUKER Biospec system, equipped with a 
volume resonator to allow for whole-body imaging of the mouse. After the animals had 
been decapitated the cadavers were frozen at -20 °C for later use. For MR-imaging, 
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cadavers were thawed for 8 hours, measured in a prone position and fixated with tape. A 
T1-weighted sequence was performed (2D spin echo, TR = 900 ms, TE = 11.6 ms, matrix 
size 512 x 256, slice thickness = 1 mm, 34 slices, in plane field of view 4.6 cm x 4.6 cm, 8 
averages, total acquisition 30 min). Using this sequence, MR-images provide a strong 
contrast between fat and muscular/organ tissue. In addition, as compared to T2-weighted 
images, free liquids also display low intensity and can therefore be clearly differentiated 
from fat. To achieve full body coverage, two slice packages with one slice overlap were 
scanned subsequently without repositioning of the mouse, covering the complete abdomen 
from tail to liver. 
Anatomical images were analyzed using the ParaVision software (BRUKER,Germany). 
For each slice, regions of interests were set including visceral tissue, and excluding 
subcutaneous, cutaneous and skeletal muscle compartments. The fat compartment was 
analyzed based on these regions along with an image intensity threshold. To account for the 
potential variability of absolute image intensities in different slices, the image intensity of 
fat was determined per each slice using an intensity histogram, identifying the maximum of 
the fat peak distribution. Based on this value, an absolute lower threshold was calculated 
corresponding to 2/3 of fat peak intensity. With this threshold, fat intensities could clearly 
be distinguished from other tissue components. Cutaneous and subcutaneous fat 
compartments were identified by summing all image pixels above the threshold excluding 
visceral volumes. Total fat was estimated by summing the areas of the respective fat 
compartment in all slices. Subsequently, relative ratios of visceral and subcutaneous fat 
were calculated.  
 
2.8 Statistics 
The commercially available program SPSS 12 was used for statistical analysis. 
Comparisons of two conditions were made by unpaired t-test or in case of fur condition by 
the non-parametric Mann-Whitney-U test. When more than two groups were compared a 
one-way analysis of variance (ANOVA) was used, followed by post-hoc Tukey test. In case 
of fur condition, a non-parametric Kruskal-Wallis Test was performed, followed by Mann-
Whitney-U tests. Morning/evening hormone levels were analyzed with a 2-way ANOVA, 
with condition as a between factor and time as a within factor. For the analysis of the 
corticosterone/ACTH ratio the absolute levels were first calculated in percent, with the 
mean value of the control group set at 100%. For insulin in project 5, in case of one missing 
observation, missing data were estimated by linear imputation using the remaining 
Material and methods 
 29
observations as predictors in a multiple regression analysis. At the age of six month these 
were 9,2% of the data, at the age of twelve months 5,6%. The level of significance was set 
at p<0.05; a trend was accepted with p<0.1. Data are presented as mean ± SEM.  
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1. Persistent neuroendocrine and behavioral effects of a novel,  
 etiologically relevant mouse paradigm for chronic social stress  
 during adolescence 
  
Chronic stress is generally considered a key risk factor for the development of a variety of 
human diseases (Anisman and Zacharko, 1992). Specifically anxiety and depressive 
disorders have frequently been associated with preceding periods of chronic stress or 
stressful life events (Post, 1992; Amat et al., 2005). In addition to psychiatric disorders, 
chronic or severe stress has also been implicated in a variety of other diseases, such as the 
metabolic syndrome (including diabetes type II), cardiovascular disease and hypertension 
(Henry and Stephens, 1977; Pickering, 2001; Tennant, 2001). 
To study the multiplicity of neurochemical pathways that are affected by chronic stress, a 
wide range of stimuli and paradigms have been used to induce a state of stress pathology. 
The more frequently used rodent paradigms for chronic stress often consist of the repeated 
exposure of the animal to physical stressors, such as electric shock, water immersion or 
restraint. However, large differences exist in the duration of the stressor, ranging from 2 to 
16 hours per day for 7 to 28 days (Ader and Grota, 1970; Ottenweller et al., 1989; Aguilera, 
1994; Conrad et al., 1996; Anisman et al., 1998). Despite the intensity of the stressors, 
many of these paradigms do not fulfill the criteria of chronic stress, as the stressors are only 
applied for a relatively short time per day or for only a few consecutive days. In order to 
circumvent the additional problem of habituation and predictability, Willner and colleagues 
developed a paradigm of chronic mild stress (CMS), where different types of mild stressors 
are alternated (Willner, 2005). Mice or rats subjected to CMS have been shown to display a 
variety of behavioral changes mimicking clinical symptoms of depressed patients (Willner, 
2005). However, these procedures do not take into account the etiology of human stress-
associated disorders, as the majority of stressful stimuli in humans that have been shown to 
increase the risk of psychiatric disorders are of a social nature (Brown and Prudo, 1981). In 
an attempt to investigate the neurobiological mechanisms underlying disease susceptibility 
caused by social stress, it is crucial that the animal model meets the requirements of 
construct validity and, therefore, investigates the consequences of social stress in rodents 
(Geyer and Markou, 1995).  
Social stress is probably one of the most pervasive stressors in humans and social animals 
(Bartolomucci et al., 2005; Fuchs, 2005). Animals exposed to inescapable social stress 
situations for a long time show extreme increases of their hypothalamic-pituitary-adrenal 
(HPA) system activity and a high mortality rate (Albeck et al., 1997). There are a number 
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of experimental designs relying on social stress, such as the social defeat paradigm in rats 
and mice, the sensory contact model in mice or the visible burrow system in rats (Ader, 
1969; Blanchard et al., 1995; Albeck et al., 1997; Koolhaas et al., 1997b; Ahima et al., 
1998; Stefanski, 2000; Aguilera et al., 2001; Stefanski, 2001; Veenema et al., 2003). A 
number of other species have also been extensively studied with regard to the behavioral 
and neuroendocrine consequences of chronic stress and social status, such as the guinea pig, 
the marmoset or the squirrel monkey (Sachser et al., 1998; Dettling et al., 2002; Levine and 
Mody, 2003; Parker et al., 2005). Few studies have also indicated that some of the observed 
neuroendocrine and behavioral effects evoked by these stressors persist even if the stress is 
discontinued, which is a crucial factor with regard to human pathology (Tsankova et al., 
2006). A major drawback of these paradigms is that they are relatively work intensive and 
space consuming so that only a few animals per group can be tested in a specific 
experiment. This is of particular importance in view of individual differences in the 
susceptibility to chronic stress and stress-induced pathologies due to genetic or epigenetic 
variability.  
An important characteristic of chronic stress paradigms is the age, at which the animals are 
exposed to the stressor. There are many indications that across the life span there are 
specific windows of vulnerability, where high levels of stress have an increased impact on 
further development (Heim and Nemeroff, 2001; Spencer et al., 2006; Avital et al., 2006). 
Many of the available chronic stress paradigms have been tested in young adult mice and 
rats (about 3 months of age). However, a high vulnerability has also been postulated in the 
adolescent period, due to the many still ongoing hormonal and neurodevelopmental 
processes (Tsoory et al., 2007). Especially social stressors are likely to have a high impact 
during this time as puberty seems crucial for the acquisition of social skills, which form the 
basis of social interactions and stability during adulthood (Sachser et al., 1998). Thus, the 
adolescent period is a highly adaptive period, where behavioral and neuroendocrine set 
points are fine tuned.  
In the current studies we therefore developed a novel mouse paradigm, which utilizes 
chronic social stress as a key pathogenic factor during adolescence. Based on early work by 
the groups of LeMoal and Henry in rats (Henry and Stephens, 1977; Klein et al., 1992; Arai 
and Widmaier, 1993), this paradigm creates an unstable social environment for a prolonged 
period of time. In this paradigm the animals are exposed to a continuous stressful situation, 
which they cannot escape from and which they are unable to adapt to. Another important 
advantage is the applicability of this paradigm to a large number of animals. Here we 
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characterize the paradigm with respect to effects on neuroendocrine and behavioral 
functions. We report persistent effects of this novel paradigm on stress-related 
physiological, neuroendocrine and behavioral parameters and their reversibility by a 
clinical efficacious antidepressant (the selective serotonin-reuptake inhibitor paroxetine) or 
CRH receptor type 1 (CRHR1) -antagonist treatment. 
 
Experimental design 
Experiment 1 
In order to assess corticosterone blood levels during the stress procedure, basal morning tail 
blood samples of 12 control and 12 chronic stress animals were taken on the day before 
single housing (three days after the last rotation).  
For the long-term effects of chronic stress a total of 96 animals (48 control and 48 chronic 
stress animals) were used. A subgroup of 12 control and 12 chronic stress animals were 
used for neuroendocrine testing 7 days after the termination of group housing. Evening 
blood samples were taken between 16.00h and 18.00h by tail cut (Fluttert et al., 2000). The 
fur state of the animals was rated by two independent researchers according to a 4-point 
scale (Mineur et al., 2003; Ducottet and Belzung, 2005), with 1 as the best and 4 as the 
worst fur condition. The next morning, the animals were decapitated under basal 
conditions. The remaining animals were tested in the following behavioral tests: open field 
test (after 8-9 days of single housing), plus maze (after 10 days of single housing) and 
novelty-induced suppression of feeding (after 11-12 days of single housing).  
 
Experiment 2 
A total of 152 animals (108 chronic stress, 44 control) were used. 3 weeks after the start of 
the chronic stress procedure, 36 animals of the chronic stress group were treated with the 
antidepressant paroxetine and another 24 animals with the CRHR1 antagonist DMP696 for 
four weeks until the end of the stress procedure. At the start of the drug treatment animals 
of the chronic stress group showed clear symptoms of stress. After 1 week of single 
housing with no further drug treatment, 19 control animals, 12 animals of the untreated 
chronic stress group, 10 animals of the paroxetine treated chronic stress group and 10 
animals of the DMP696 treated chronic stress group were used for neuroendocrine testing 
as described in experiment 1. The remaining animals underwent the same behavioral tests 
as described in experiment 1. The experimental design is summarized in figure 2.  
Results 
 
Figure 2: Experimental design. 
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Experiment 1 
Social status and interactions 
Social and hierarchical interactions of the animals were determined in a separate set of 
animals over the first 4 weeks of stress exposure and in control animals. The results of this 
analysis are presented in table 1. Our data demonstrate that in the chronic social stress 
group the number of aggressive attacks is significantly higher compared to control animals, 
already after 1 week of exposure to the stress paradigm. In addition, the latency of an 
aggressive attack is much shorter compared to control animals. The magnitude of these 
effects increases over time. Thus, in control animals, a stable social status of the animals 
developed within the first 2 weeks of group housing. A constant hierarchy without the 
presence of a female has been shown to represent a non-stressed housing condition and 
therefore a valid control group (Bartolomucci et al., 2001; Bartolomucci et al., 2004). In 
contrast, animals exposed to the chronic stress paradigm were not able to establish a stable 
social environment.  
Table 1: Hierarchical interactions 
control chronic stress control chronic stress
N = 16 N = 16 N = 16 N = 16
week 1 1.25 +/- 0.63 3.25 +/- 3.25 31.25 +/- 9.87 46.25 +/- 13.75
week 2 0.5 +/- 0.5 2.75 +/- 1.11 56.25 +/- 3.75 37.5 +/- 8.29
week 3 0.5 +/- 0.5 6.5 +/- 4.27 55.00 +/- 5.00 35.5 +/- 14.61
week 4 1.0 +/- 0.71 7.5 +/- 3.01 42.00 +/- 10.7 5.5 +/- 1.44
number of aggressive attacks latency to first aggressive attack
 
Physiological data 
Body weight was determined every other week prior to the cage change. There were no 
differences between the groups in mean body weight during the experiment (p<0.65, t-test). 
Adrenal and thymus glands of 12 control and 12 chronic stress animals sacrificed after 7 
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days of single housing were dissected and weighed (table 2). The relative weight of the 
adrenal glands in chronically stressed animals was significantly increased, while relative 
thymus weight was significantly decreased (t-test, for p value see table 2).  
The fur condition of the 12 control and 12 chronic stress animals was rated carefully by two 
independent observers according to a 4 point scale prior to blood sampling, with a higher 
number corresponding to a worse fur state. A significant deterioration of the fur state of 
chronically stressed animals could be detected (Mann-Whitney U test, Z= -3.089, p=0.002) 
Table 2: Long-term effects of chronic stress exposure on adrenal weight, thymus weight and fur state. 
*significant from control group, p<0.05 
 control chronic stress p value 
N = 12 N = 12
adrenal weight 
(mg/g bw) 
0.077 ± 0.006 0.123 ± 0.015* 0.008 
thymus weight 
(mg/g bw) 1.388 ± 0.1 0.99 ± 0.109* 0.009 
fur state 1.166 ± 0.11 2.091 ± 0.25* 0.002 
 
 
Neuroendocrine data 
Corticosterone basal levels were measured directly at the end of the chronic stress exposure 
in a separate cohort of animals to validate the effectiveness of the paradigm (figure 3A). 
Three days following the last cage member rotation, basal levels of animals from the 
chronic stress group were significantly higher compared to group housed control animals 
(p<0.05, t-test). 
After 7 days of single housing basal evening and morning corticosterone and ACTH plasma 
levels were measured (figure 3B and 3C). ANOVA with repeated measures (time as within 
factor, treatment as between factor) revealed a significant effect of time for corticosterone 
(F (1,21) = 48.148 (p<0.001)) and ACTH (F (1,21) = 14.843 (p<0.01)). No significant 
interaction between time and condition was observed (corticosterone: (F (1,21) = 3.712 
(p<0.068)); ACTH: (F (1,21) = 4.178 (p<0.06)). Morning corticosterone levels are higher in 
chronic stress animals compared to controls, while ACTH levels are significantly 
decreased. The analysis of the circadian corticosterone rhythm (difference of morning-
evening values) showed that it was flattened in the chronic stress group (p = 0,064). 
Further, in the morning chronic stress animals had a significantly higher 
corticosterone/ACTH ratio compared to control animals (figure 3D, p<0.05, t-test). 
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* 
Figure 3: Effects of chronic stress exposure on HPA axis function. (A) Morning corticosterone levels after 7 
weeks of chronic stress exposure. (B) Morning and evening corticosterone levels after 1 week of recovery 
from chronic stress. (C) Morning and evening ACTH levels after 1 week of recovery from chronic stress. (D) 
corticosterone / ACTH ratio after 1 week of recovery from chronic stress. Control = C; chronic stress = S. 
N=12 per group. * significant from control group, p<0.05 
 
We also analyzed basal gene expression of CRH and AVP mRNA in the PVN, CRH 
mRNA in the amygdala as well as MR and GR mRNA expression in the hippocampus 
(figure 4). We found a significant decrease of MR mRNA levels in the CA2 area of the 
hippocampus in chronically stressed animals (p<0.05, t-test). GR mRNA was significantly 
decreased in the CA1 region (p<0.05, t-test). No changes of CRH and AVP expression 
were observed between the two groups after 7 days of single housing (t-test, p=0.55 and 
0.23, respectively). 
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B 
D 
Figure 4: Expression levels of MR mRNA in the CA2 region of the hippocampus (A) and GR mRNA in the 
CA1 region of the hippocampus (C) in previously chronically stressed and control animals after 1 week of 
recovery. (B) Representative MR expression autoradiograph. (D) Representative GR expression 
autoradiograph. Control = C; chronic stress = S. N=12 per group. * significant from control group, p<0.05 
 
Behavioral data 
To assess long-term alterations in behavior due to chronic stress exposure we tested the 
animals in anxiety-related behavioral tests. In the open field (figure 5A), the locomotor 
adaptation in the first 5 minutes was significantly decreased in chronic stress animals 
(p<0.05, t-test). General locomotor activity in the last 20 minutes of the open field exposure 
was not different in both groups.  
Chronically stressed animals also displayed an enhanced anxiety-related behavior in the 
novelty-induced suppression of feeding paradigm (figure 5B). Control animals initiated the 
snack consumption significantly faster compared to previously stressed animals (p<0.05, t-
test).  
In the elevated plus maze (figure 5C-D), control animals entered the open arms more often 
(p<0.05, t-test) and spent more time in the open arms compared to animals from the chronic 
stress group (p<0.1, t-test). Further, the number of head dips was significantly reduced in 
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the chronic stress group (p<0.05, t-test) The number of total arm entries was not different 
between the groups (p=0.51, t-test). 
 
Figure 5: Open field: Long-term effects of chronic social stress on locomotor adaptation during the first 5 
minutes of open field exposure (A). Novelty-induced Suppression of Feeding: Effects of chronic stress on the 
time till initiation of consumption of a palatable snack (B). Plus Maze: Persisting effects of chronic social 
stress on the time the animals spend in the open arms (C) and the number of entries in the open arms (D). 
Control = C; chronic stress = S. N=12 per group. * significant from control group, p<0.05 
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Experiment 2 
Physiological data 
Body weight was determined every other week prior to the cage change. ANOVA revealed 
a significant interaction between time and treatment (F (3,96) = 11.602 (p<0.001)). There 
was no difference in body weight between untreated chronic stress and control animals. 
Paroxetine, but not DMP696, treatment resulted in a slight but significant increase in body 
weight after 4 weeks of treatment. Adrenals and thymus glands were dissected and weighed 
after 7 days of single housing under basal conditions. For both organs, ANOVA revealed an 
effect of condition (adrenals: F (3,48) = 9,166 (p<0.001); thymus: F (3,50) = 7,100 
(p<0.001)) (table 3). Chronic stress resulted in a significant increase in adrenal weight. This 
effect was prevented by DMP696 or paroxetine treatment during stress exposure. Thymus 
weight was significantly reduced in the untreated chronic stress group compared to control 
animals. Paroxetine, but not DMP696, ameliorated this effect. 
The fur condition of all animals was inspected carefully by two independent observers 
according to a 4 point scale (table 3). ANOVA revealed a significant effect of condition (F 
(3,99) = 21,95 (p<0.001)). Chronically stressed animals scored significantly worse in their 
fur state compared to control animals. Treatment with either paroxetine or DMP696 did not 
affect the fur state of the animals.  
Table 3: Influence of DMP696 or paroxetine treatments during chronic social stress exposure on adrenal 
weight, thymus weight and fur state. * significant from control group, p<0.05 
control chronic stress chronic stress        + paroxetine
chronic stress        
+ DMP696 F-value p value
N = 12 N = 12 N = 10 N = 10
adrenal weight 
(mg/g bw) 0.058 ± 0.007 0.096 ± 0.008* 0.049 ± 0.005 0.063 ± 0.007 9.166 0.001
thymus weight 
(mg/g bw) 1.52 ± 0.057 1.009 ± 0.067* 1.28 ± 0.081 1.183 ± 0.137* 7.1 0.001
fur state 1.31 ± 0.07 2.23 ± 0.13* 2.02 ± 0.07* 2.36 ± 0.12* ---- 0.001
 
 
Neuroendocrine data 
For corticosterone (figure 6A), ANOVA revealed a main effect of condition (F(3,47) = 
2.924 (p<0.05)). Morning basal levels of circulating corticosterone were significantly 
increased in chronically stressed mice. This effect was prevented by treatment with 
DMP696 or paroxetine during stress exposure. No significant differences were found for 
ACTH (figure 6B). However, ANOVA revealed a significant effect for the 
corticosterone/ACTH ratio (F(3,41) = 2.932 (p<0.046)). Chronic stress animals had a 
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significantly higher corticosterone/ACTH ratio compared to control animals. This effect 
was abolished by treatment with either paroxetine or DMP696 (figure 6C).  
 
Figure 6: Influence of DMP696 or paroxetine treatment during chronic social stress exposure on morning 
corticosterone (A) and ACTH (B) as well as corticosterone/ACTH ratio (C) after one week of recovery. 
Control = C; chronic stress = S; chronic stress + paroxetine = S+P; chronic stress + DMP696 = S+D. N=12 
per group. * significant from control group, p<0.05 
 
We also analyzed basal gene expression of MR and GR mRNA in the hippocampus (figure 
7). For MR, ANOVA revealed a significant condition effect (CA1: F(3,34) = 5.236 
(p<0.005); CA3: F(3,34) = 4.485 (p<0.01); DG: F(3,34) = 5.922 (p<0.003)). The mRNA 
expression of MR in chronic stress animals was significantly decreased in the CA2 area 
compared to control animals. Paroxetine treatment reversed this effect in the CA2 area, and 
even significantly increased MR expression compared to control animals in the CA3 and 
dentate gyrus regions. DMP696 treatment had no effect on MR expression. For GR, 
ANOVA revealed a significant effect in the CA1 region (F(3,29) = 4.186 (p<0.015)). 
Chronic stress significantly decreased GR expression in the CA1 region. This effect was 
prevented by DMP696 treatment, while paroxetine treatment had no effect on GR 
expression in the chronic stress animals.  
 
Figure 7: Influence of DMP696 or paroxetine treatment during chronic social stress exposure on long-term 
changes in MR mRNA expression in the CA1 (A), MR mRNA expression in the CA2 (B) and GR mRNA 
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expression in the CA1 (C). Control = C; chronic stress = S; chronic stress + paroxetine = S+P; chronic stress 
+ DMP696 = S+D. N=12 per group. * significant from control group, p<0.05 
 
Behavioral data 
Based on the results obtained in experiment 1 we tested the animals according to anxiety-
like behavior and locomotor activity.  
We recorded the locomotor activity of the different groups in an open field test. For the 
locomotor adaptation in the first 5 minutes, ANOVA revealed a main effect of condition 
(F(3,47) = 3.852 (p<0.016)). Chronic stress resulted in a significant decrease of locomotor 
adaptation compared to control animals (figure 8A). This effect was reversed by paroxetine 
and DMP696 treatment. Basal locomotor activity during the last 20 minutes of open field 
exposure did not differ between the groups.  
In the novelty-induced suppression of feeding test (figure 8B), animals which were 
chronically stressed showed a longer latency to consume the snack in the open field arena 
compared to control, DMP696 and paroxetine treated animals. However, due to a large 
variation in the chronic stress group, this effect was not significant (ANOVA: (F (3,44) = 
1.362 (p = 0.268)). 
In the elevated plus maze test ANOVA revealed a main effect of condition for the time 
spent in the open arms (F (3,41) = 3.596 (p = 0.022)). Chronic stress animals spent 
significantly less percent of time in the open arms of the plus maze and entered the open 
arms less often compared to controls (figure 8C-D). These effects were reversed by 
DMP696 treatment, but not by paroxetine treatment. Further, there was a significant effect 
in the number of head dips (F (3,41) = 3.204 (p = 0.033)). Chronic stress animals performed 
significantly less head dips compared to controls. Paroxetine or DMP696 treatment did not 
affect this parameter. There was no difference in the number of total arm entries between 
the groups, indicating similar levels of locomotor activity (F (3,43) = 1.942 (p = 0.138)).  
Results 
 
Figure 8: Influence of DMP696 or paroxetine treatment during chronic social stress exposure on long-term 
changes in anxiety-related behavior. Open field: Treatment effects on locomotor adaptation during the first 5 
minutes (A). Novelty-induced Suppression of Feeding: Treatment effects on the time till initiation of almond 
consumption (B). Plus Maze: Treatment effects on time spent in the open arms (C) and number of entries to 
the open arms (D). Control = C; chronic stress = S; chronic stress + paroxetine = S+P; chronic stress + 
DMP696 = S+D. N=12 per group. * significant from control group, p<0.05 
 
Discussion 
In the present study we have characterized a novel chronic stress paradigm, which is based 
on social stress between group-housed male mice during adolescence. The stressor consists 
of an unpredictable social environment, which is constantly present during the stress 
procedure and unavoidable for the individuals. This paradigm was developed for three 
specific reasons. First, we aimed to create an animal paradigm of chronic social stress, 
where stress is actually chronic, unavoidable, non-adaptive and relevant to the clinical 
situation of stress-related pathophysiology. Second, the effects of chronic stress exposure 
should be evident and persistent even when the stressor is discontinued. Third, the 
paradigm should be applied during a time window of high vulnerability. Finally, the 
paradigm should be easily applicable without special equipment for a large number of 
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animals, in order to facilitate drug screening or studies investigating genetic and individual 
differences in the response to chronic social stress. Ideally, an animal model for a human 
clinical condition should display certain symptoms characteristic for the disease (face 
validity), the model should display reduced symptoms when treated with a clinically 
efficacious drug (predictive validity) and, finally, the neurobiological mechanisms 
underlying the symptomatology as well as the psychological causes should be identical 
(construct validity).  
We have demonstrated that the application of this procedure indeed results in chronic stress 
for the animals. Most importantly, a variety of effects of this stress procedure are persistent, 
even when the stressor is discontinued and the animals are single housed under resting 
conditions. The measurement of long-term alterations of neuroendocrine and behavioral 
parameters due to chronic stress instead of the immediate effects of chronic stress is crucial, 
as human pathologies often develop with a latency to the experienced stress exposures (e.g. 
childhood trauma). Therefore we did not focus on the acute effects of chronic stress 
exposure, which often represent non-pathological adjustments to the stressful situation. So 
far there are only few reports in the literature that report long-term consequences of acute or 
chronic stress (Ahima et al., 1998). Our data showed that after 7 days of rest after the stress 
procedure previously chronically stressed animals display a lasting sensitization of adrenal 
activity. Morning ACTH levels of chronic stress animals were lower compared to controls, 
while the corticosterone production from the markedly enlarged adrenals was enhanced. 
Thus, lower ACTH concentrations are capable to induce a higher basal corticosterone 
secretion. In addition, these animals develop a flattened circadian corticosterone rhythm 
compared to non-stressed controls, a phenomenon which is also observed in depressed 
patients (Deuschle et al., 1997; Weber et al., 2000). The changes in adrenal and thymus 
weights also indicate a lasting adaptation of the HPA axis. These data are in concordance 
with the early work of LeMoal and Henry, who also found increased adrenals, thymus 
diminution and increased corticosterone secretion (Henry and Stephens, 1977; Klein et al., 
1992). 
In contrast to chronic stress paradigms during adulthood, we did not detect a decrease in 
body weight in the stressed animals, even though the changes in corticosterone secretion, 
adrenal and thymus weight in our paradigm were robust. There are a few potential 
explanations for this unexpected result. First, it is possible that body weight regulation 
differs between adult and juvenile mice. Thus, growth factors may be less influenced by 
differences in corticosterone secretion during adolescence. Alternatively, adolescent mice 
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may be able to compensate body weight loss more easily than adult mice. Thus, chronic 
social stress is not always accompanied by a decelerated gain in body weight. 
The peripheral neuroendocrine data indicated that chronic stress exposure might have 
resulted in a permanent alteration of central stress regulation. Indeed we found a marked 
decrease of GR and MR expression in different sub regions of the hippocampus. These 
findings are in line with previous reports demonstrating a down-regulation of these steroid 
receptors in the hippocampus following chronic stress in other species (Herman and 
Spencer, 1998; Meyer et al., 2001; Bartolomucci et al., 2003a). In contrast to other reports, 
we did not find alterations in the expression of CRH or AVP in the chronically stressed 
animals (Ader, 1969). However, as these effects of altered CRH or AVP gene expression 
have always been observed directly at the end of a chronic stress procedure, it is quite likely 
that they have normalized in the absence of a stressor and do not persist after the stressor is 
discontinued. Alternatively, due to an altered negative feedback, differences of CRH and 
AVP expression may only be observed under conditions of an activated HPA axis. Thus, 
our data demonstrate a long-term alteration of the central and peripheral HPA function as a 
consequence of prolonged social stress exposure.  
As chronic stress in humans is regarded as a risk factor for developing a number of 
psychopathological symptoms, among them anxiety and depression, we have examined the 
behavior of chronically stressed animals 7-14 days following the termination of the stress 
procedure. Chronic stress exposure permanently altered anxiety-related behavior compared 
to controls. Previously stressed animals showed a decreased locomotor adaptation in a 
novel environment compared to control mice, indicating an increased anxiety in the novel 
situation. Furthermore, chronic stress exposure resulted in a more anxious phenotype in the 
plus maze and novelty-induced suppression of feeding paradigm. Both tests have been 
intensively validated to reliably measure anxiety in rodents (Rex et al., 1998; Rodgers et al., 
2002; Merali et al., 2003; Plamondon and Khan, 2005). Thus, certain aspects of anxiety are 
persistently affected by previous chronic stress exposure as a behavioral adaptation to the 
environmental demands.  
Besides the increase in anxiety-like behavior, chronically stressed animals displayed other 
symptoms of stress exposure, such as decreased fur quality (Ducottet and Belzung, 2005). 
This deterioration of fur state can be explained by a decreased grooming behavior which 
represents a form of personal neglect and decreased grooming motivation.  
In the second part of this study, we investigated whether the long-term effects of chronic 
social stress can be prevented by antidepressant treatment during stress exposure. For this 
Results 
 46
experiment we chose two drugs with different mechanisms of action, a selective serotonin 
reuptake inhibitor (paroxetine) and a CRH receptor 1 antagonist (DMP696). While the 
former is a well known and widely used antidepressant, the latter represents a new class of 
putative antidepressants, aimed directly at normalizing a central CRH hyper-drive of the 
HPA axis (Keck and Holsboer, 2001). Both compounds were able to normalize some of the 
long-term effects of chronic stress exposure on HPA system function and behavior. This 
finding is especially intriguing, as both drugs have completely different sites and 
mechanisms of action. As DMP696 inhibits both the peripheral and central CRHR1 system, 
lasting chronic stress effects mediated by elevated peripheral corticosterone concentrations 
or an enhanced activity of central CRH systems should be blocked by the drug. 
Accordingly, DMP696 treatment during stress exposure prevented peripheral alterations as 
adrenal enlargement, altered corticosterone/ACTH ratio and enhanced morning 
corticosterone levels. Interestingly, paroxetine treatment also normalized these peripheral 
HPA activity markers (Keck et al., 2003). In addition, both drugs were at least partly able to 
reverse the increased anxiety phenotype observed in chronic stress animals. Thus, even 
though both drugs act via different neurotransmitter pathways, their effects on stress 
hormone regulation are similar. These data further support earlier data relating an aberrant 
stress hormone regulation to causality of depression and suggesting that a normalization of 
the HPA system might be the final step necessary for stable remission of the disease 
(Holsboer, 1999; Holsboer, 2000). These findings are also in line with previous reports, 
suggesting the use of CRHR1 antagonists as novel antidepressant therapy (Zobel et al., 
2000).  
The different mechanism of action of both drugs becomes apparent when studying the 
central effects of paroxetine and DMP696. In concordance with previous findings, there is a 
significant decrease in MR and GR mRNA expression in the hippocampi of chronically 
stressed animals. Interestingly, paroxetine treatment affected mainly the expression of MR, 
while DMP696 treatment selectively prevented the decrease in GR expression. In non-
stressed mice, acute CRHR1 antagonist treatment has already been shown to influence both 
MR and GR expression (Post et al., 2005). In addition, a number of studies indicated 
increased MR expression after chronic SSRI treatment, with no or little effect on GR 
expression (Lopez et al., 1998; Yau et al., 2002; Pariante et al., 2004). Thus, both drugs 
seem to influence peripheral HPA function by different central pathways.  
A very interesting aspect of the persisting effects of chronic social stress in rodents and 
humans are individual differences. Some individuals seem to be highly vulnerable to 
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chronic stress exposure, while others are largely unaffected. The variability of our data is a 
strong indication for individual differences in stress resistance. As our chronic social stress 
model is ideally suited for the use of large experimental groups, the comparison of 
vulnerable and resistant phenotypes within a chronic stress group should provide valuable 
information on the interaction between genes and environment.  
In summary, our novel chronic stress paradigm results in persistent alterations of HPA axis 
function and behavior. The neuroendocrine and behavioral consequences of chronic social 
stress can be partly prevented by treatment with a CRHR1 antagonist or by treatment with 
the SSRI paroxetine. Therefore, this stress paradigm fulfills the requirements of a reliable 
and valid animal model mimicking the human condition of stress-related diseases with 
respect to its etiology, symptomatology, treatment and biological basis. By applying this 
paradigm it will now be possible to investigate the interaction between genetic 
susceptibility and environmental factors, i.e. to what extent the long-term effects of chronic 
stress are dependent on a specific genetic background. 
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2. Long-term behavioral and neuroendocrine alterations  
        following chronic social stress during adolescence:  
       implications for stress-related disorders 
 
Chronic stress and the resulting characteristic dysregulation of the hypothalamic-pituitary-
adrenocortical (HPA) axis clearly enhance vulnerability to a variety of diseases, including 
both affective and anxiety disorders (Chrousos and Gold, 1992; Anisman and Zacharko, 
1992; Holsboer, 1999; McEwen, 2000; Amat et al., 2005). Chronically elevated cortisol 
levels are known to play an important role in the development of major depression in 
humans (Holsboer, 1999) and a high percentage of patients suffering from major depression 
are characterized by a hyperactive HPA axis (Holsboer and Barden, 1996; Rybakowski and 
Twardowska, 1999; Holsboer, 2000).  
The mechanisms that lead to depression-associated HPA hyperactivity, including increased 
central corticotropin-releasing-hormone (CRH) levels (Raadsheer et al., 1994; Raadsheer et 
al., 1995), are still not completely understood. Genetic and experience-related factors may 
interact to induce manifold changes in corticosteroid receptor signaling, finally resulting in 
hypersecretion of both CRH and vasopressin (for review see: de Kloet et al., 1998). Several 
genetic susceptibility markers have recently been identified, for example a specific single 
nucleotide polymorphism in the FKBP5 gene, a co-chaperone modulating glucocorticoid 
receptor function, which is associated with an increased recurrence of depressive episodes 
(Pezawas et al., 2005; Ising and Holsboer, 2006). Besides genetic risk factors, increasing 
evidence shows an important role of environmental factors or stressful life events for the 
development of affective disorders in adulthood (Paykel et al., 1969; Coplan et al., 1996). 
Thus, both genetic predisposition as well as life experience seem to contribute to one’s 
susceptibility to stress and acute life events, and the individual risk of developing 
depression. Moreover, normalization of the HPA system has been shown to be a 
prerequisite for stable remission of the disease (Zobel et al., 1999; Holsboer, 2000), which 
has been shown to occur during successful antidepressant treatment (Barden et al., 1995), 
again supporting the importance of the stress hormone system in the development and 
maintenance of affective disorders. 
As experimental variation of early environment and stress exposure cannot be performed in 
humans for obvious reasons, preclinical studies using animal models are indispensable to 
improve our understanding of the consequences of chronic stress on stress responses later 
in life. Most of the effects described so far in the various existing stress models are limited 
to acute effects, observed only shortly after termination of the different stressors. In many 
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of these paradigms acute alterations of neuroendocrine parameters, like elevated CRH and 
arginine-vasopressin (AVP) expression levels, can be detected. Also, behavioral alterations 
could be observed in stressed animals displaying increased depression-like and anxiety-
related behavior (Ottenweller et al., 1989; Aguilera, 1994; Gregus et al., 2005; Willner, 
2005). However, the data on long-term effects of chronic stress are very limited (Tsankova 
et al., 2006), which are a crucial factor with regard to human pathology and disease 
development according to the stress-diathesis model (Morley, 1983). In addition, as the 
majority of stressful stimuli that enhance the risk for psychiatric disorders in humans are of 
a social nature, the etiology of human stress-associated disorders has to be taken into 
account.  
Trying to overcome the limitations of the existing models, we recently developed a novel 
mouse paradigm for chronic social stress during adolescence (Schmidt et al., 2007), which 
is based on subjecting the animals continuously for seven weeks to an unstable social 
environment. Social stressors are likely to have a high impact during adolescence and early 
adulthood, which is a period of life that is highly adaptive and during which substantial 
remodeling occurs in areas involved in emotional and learning processes (Avital and 
Richter-Levin, 2005; Tsoory et al., 2007). We demonstrated significant effects of this 
chronic stress paradigm with respect to physiological, neuroendocrine and behavioral 
parameters after the stressor was discontinued for at least seven days (Schmidt et al., 2007). 
In addition, many of the adverse consequences evoked by the chronic stress could be 
prevented by simultaneous antidepressant treatment. Our data indicate that this paradigm 
closely meets the criteria of face, construct and predictive validity for chronic stress in 
humans (Willner, 1984; Geyer and Markou, 1995). 
One of the central questions with regard to chronic stress exposure is which of the acute 
effects of the stress experience persist and in which way this early experience might 
enhance disease vulnerability. To address this question, we investigated the persistent 
effects of chronic social stress exposure 12 months after the cessation of the stressor in 
comparison to the observed acute effects. Our current data identify physiological, 
functional and behavioral parameters that are persistently altered or affected by chronic 
stress exposure throughout lifespan, thereby possibly altering the vulnerability of these 
animals for disease.  
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Experimental design
Experiment 1: immediate stress effects 
For the acute effects of chronic social stress a total of 64 animals (32 control and 32 chronic 
stress animals) were used. A subgroup of 16 control and 16 chronic stress animals were 
used for neuroendocrine testing four days after the last change in group composition. 
Evening blood samples were taken between 16.00h and 18.00h by tail cut (Fluttert et al., 
2000}. On the next morning, the animals were sacrificed under basal conditions (see: 
Sampling procedure). The remaining animals were tested in the following behavioral tests: 
elevated plus maze, novelty-induced suppression of feeding and open field. Body weight 
was determined every two weeks prior to cage change. 
 
Experiment 2: persistent stress effects 
For the investigation of persisting effects of chronic stress in aged animals a total of 44 
animals (22 control and 22 chronic stress animals) were used. A subgroup of 10 control and 
10 chronic stress animals were used for neuroendocrine testing at the age of 15 months, i.e. 
12 months after termination of the stress and group housing. The animals were sacrificed in 
the morning under basal conditions. The remaining animals were tested in the following 
behavioral tests: elevated plus maze, novelty-induced suppression of feeding and open field 
test. 
 
Results 
Experiment 1 
Physiological data 
There were no differences between the groups in mean body weight during the experiment 
(t-test, p=0.366 at the end of the stress period). Adrenal and thymus glands of 16 control 
and 16 chronic stress animals, sacrificed four days after the last change in cage 
composition, were dissected and weighed (figure 9). The relative weight of the adrenal 
glands in chronically stressed animals was significantly increased (t-test, p<0.05), while 
relative thymus weight was significantly decreased (t-test, p<0.05).  
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Figure 9: Immediate effects of chronic stress on adrenal weight (A) and thymus weight (B).  
control = C; chronic stress = S; N = 16 per group. * significant from control group, p<0.05 
 
Neuroendocrine data 
Four days following the last cage member rotation, basal evening and morning 
corticosterone as well as morning ACTH plasma levels were measured. For corticosterone, 
ANOVA with repeated measures (time as within factor, treatment as between factor) 
revealed a significant effect of time (F (1,19) = 39.450 (p<0.001)) and a significant 
interaction between time and condition (corticosterone: (F (1,19) = 14.908 (p<0.01)). 
Chronic stress animals had significantly higher corticosterone levels in the morning 
(p<0.05) and lower levels in the evening (p<0.05) (figure 10A), resulting in a flattening of 
the circadian rhythm (figure 10B). For ACTH no significant differences in basal morning 
levels could be observed (t-test, p=0.208) (figure 10C). Further, the morning 
corticosterone/ACTH ratio in chronic stress animals was significantly higher compared to 
controls (t-test, p<0.05) (figure 10D).  
 
Figure 10: Immediate effects of chronic stress exposure during adolescence on HPA axis function. (A) 
Morning and evening corticosterone levels after seven weeks of chronic stress. (B) Circadian difference of 
corticosterone levels. (C) Basal ACTH levels. (D) Corticosterone / ACTH ratio after chronic stress. control = 
C; chronic stress = S; N = 16 per group. * significant from control group, p<0.05 
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We also analyzed basal gene expression of CRH and AVP mRNA in the PVN as well as 
MR and GR mRNA expression in the hippocampus (figure 11). The expression of AVP in 
the PVN was significantly higher in the chronic stress group (t-test, p<0.05). No alteration 
in CRH expression was observed between the two groups (t-test, p=0.474).  
For the MR mRNA levels we found a significant decrease in the CA1, CA2, CA3 area and 
the dentate gyrus of the hippocampus in chronically stressed animals (t-test, p<0.05). GR 
mRNA was significantly decreased in the CA1 region (t-test, p<0.05).  
 
Figure 11: Expression levels of AVP mRNA in the parvocellular part of the PVN (A), GR mRNA in the CA1 
region and the dentate gyrus of the hippocampus (B) and MR mRNA in the CA1, CA2, CA3 region and the 
dentate gyrus of the hippocampus (C). control = C; chronic stress = S; N = 12 per group. * significant from 
control group, p<0.05 
 
Behavioral data 
To asses alterations in behavior due to chronic stress exposure we tested the animals in 
anxiety-related behavioral tests. In the elevated plus maze (figure 12A), control animals 
entered the open arms significantly more often (t-test, p<0.05) and tended to spent more 
time in the open arms (t-test, p<0.1) compared to animals from the chronic stress group. 
The number of closed arm entries was not different between the groups, indicating a similar 
locomotor activity in this behavioral paradigm. Also the number of head dips, which is one 
of the best indicators for anxiety in the elevated plus maze (Fernandez, 1997), was 
significantly higher in controls (figure 12B) (t-test, p<0.05). 
Chronically stressed animals also displayed an enhanced anxiety-related behavior in the 
novelty-induced suppression of feeding paradigm (figure 12C), where control animals 
initiated the almond consumption significantly faster compared to previously stressed 
animals (t-test, p<0.05).  
In the open field, stressed animal tended to travel less in the first two minutes of the test, 
although the differences were not statistically significant (F (4,30) = 2.560 (p<0.1)) (figure 
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12D). The pattern of locomotion did not differ between both groups in the last three 
minutes of the test. 
 
 
Figure 12: Elevated plus maze: immediate effects of chronic stress on (A) the number of entries into the open 
arms and (B) on the number of head dips. (C) Novelty-induced suppression of feeding: effects of chronic 
stress on the time till initiation of consumption of a palatable snack. (D) Open field: effects of chronic stress 
on the locomotor activity of the animals. control = C; chronic stress = S; N = 16 per group. * significant from 
control group, p<0.05 
 
Experiment 2 
Physiological data 
There were no differences between the groups in mean body weight during any time of the 
experiment (t-test, p=0.347 at the age of 15 months). The adrenal glands of 10 control and 
10 chronic stress animals sacrificed at the age of 15 months were dissected and weighed. 
The relative weight of the adrenal glands did not differ between the two groups anymore (t-
test, p=0.521). Due to the natural shrinkage of the thymus gland over lifetime its weight 
could not be investigated in the aged mice. 
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Neuroendocrine data 
Basal morning corticosterone levels were determined, revealing no significant difference 
between the two groups (t-test, p=0.592). Gene expression analyses of CRH and AVP 
mRNA in the PVN as well as GR and MR mRNA expression in the hippocampus were 
performed (figure 13). The expression levels of AVP (figure 13A) and CRH mRNA were 
not significantly different between both groups of aged mice (t-tests, p=0.115 for AVP and 
p= 0.35 for CRH, respectively).  
For GR mRNA, a decrease could be detected in the CA1 region and the dentate gyrus in the 
stress group, but this effect failed to reach statistical significance (t-test, p<0.1) (figure 
13B). For MR mRNA levels we found a significant decrease in the CA3 area and the 
dentate gyrus of the hippocampus in chronically stressed animals (t-test, p<0.05) (figure 
13C).  
 
Figure 13: Expression levels of AVP mRNA in the parvocellular part of the PVN (A), GR mRNA in the CA1 
region and the dentate gyrus of the hippocampus (B) and MR mRNA in the CA1, CA2, CA3 region and the 
dentate gyrus of the hippocampus (C) in aged animals. control = C; chronic stress = S; N = 10 per group.  
* significant from control group, p<0.05 
 
Behavioral data 
For the behavioral characterization, locomotor activity and performance in anxiety-related 
tests were assessed. In the elevated plus maze, control animals did not differ from stress 
animals in terms of open arm entries (t-test, p<0.1) (figure 14A), time spent in the open 
arms, the number of closed arm entries and the total distance traveled. However, the 
number of head dips was still significantly higher in controls compared to previously 
stressed animals (figure 14B) (t-test, p< 0.05). 
In the novelty-induced suppression of feeding paradigm no persistent effects could be 
detected (figure 14C). Stress animals tended to feed the snack later than controls, but due to 
a high individual variation within each group this difference was not significant. 
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Chronically stressed and control animals initiated the snack consumption in a similar time 
range. 
In the open field, the locomotor adaptation of the animals was investigated. We found an 
overall effect between both groups (F (4,21) = 3.433 (p<0.05)) with the previously stressed 
animals displaying decreased locomotor adaptation compared to controls, predominantly in 
minute three and four of the test (p<0.05) (figure 14D). 
 
Figure 14: Elevated plus maze: persistent effects of chronic stress on the number of entries into the open arms 
(A) and on the number of head dips (B). (C) Novelty-induced suppression of feeding: persistent effects of 
chronic stress on the time till initiation of consumption of a palatable snack. (D) Open field: persistent effects 
of chronic stress on the locomotor pattern of the animals. control = C; chronic stress = S; N = 10 per group.  
* significant from control group, p<0.05 
 
Discussion 
 55
The aim of the present study was to characterize persistent neuroendocrine and behavioral 
effects of chronic social stress during adolescence obtained 12 months after cessation of the 
stressor. As a reference, and also to dissect acute stress effects from persistent ones, we also 
investigated the immediate effects of chronic stress obtained at the end of the chronic stress 
period. Our findings provide evidence that chronic stress exposure during a crucial 
developmental time period results in long-term, persistent effects on physiological and 
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behavioral parameters throughout life, which – if transferred to the human situation - may 
contribute to an enhanced vulnerability to stress-induced diseases, such as affective 
disorders (Kendler et al., 1999; Kendler et al., 2001).  
We could demonstrate robust immediate effects of the chronic stress paradigm at the 
behavioral and neuroendocrine level, adding further evidence for the validity of this novel 
animal model for chronic stress research (Schmidt et al., 2007). At the end of the stress 
period chronically stressed animals displayed significantly higher basal morning and lower 
evening corticosterone levels, resulting in a flattened circadian rhythm compared to non-
stressed controls. Interestingly, a shift or flattening of circadian stress hormone secretion is 
a phenomenon that is also observed in depressed patients (Deuschle et al., 1997; Weber et 
al., 2000). Both the increase in adrenal weights and the decrease in thymus weights are 
robust immediate effects after the chronic stress procedure, further indicating a chronic 
activation of the HPA axis during the stress phase. In addition to alterations in peripheral 
hormone secretion, we could detect concomitant changes in central stress parameters: We 
found a marked decrease of GR mRNA and MR mRNA expression in different sub regions 
of the hippocampus as well as a marked increase in AVP mRNA expression in the 
hypothalamic PVN. These findings are in line with previous reports demonstrating a down-
regulation of hippocampal steroid receptors or an up-regulation of hypothalamic AVP 
following chronic stress procedures (Makino et al., 1995; Albeck et al., 1997; Herman and 
Spencer, 1998; Meyer et al., 2001; Bartolomucci et al., 2003a). As chronic stress is 
regarded a key risk factor to develop a number of psychopathological symptoms in humans 
including anxiety and depression-like symptomatology (Kendler et al., 1999; Kendler et al., 
2001), we investigated the behavior of chronically stressed animals in relevant behavioral 
paradigms. Generally, chronic stress exposure increased anxiety-related behavior compared 
to controls. Chronically stressed animals displayed a more anxious phenotype immediately 
after stress termination in the novelty-induced suppression of feeding paradigm and the 
elevated plus maze,. Both tests have been validated to reliably measure anxiety in rodents 
(Rex et al., 1998; Rodgers et al., 2002; Merali et al., 2003). As expected, the immediate 
effects in this paradigm are more pronounced compared to the effects obtained seven to ten 
days after stress cessation as described earlier (Schmidt et al., 2007). For instance, we now 
detected a significant increase in hypothalamic AVP mRNA expression, which seems to 
represent a more acute adaptation to the stressful situation, as it has been found to be 
normalized again seven days after the stress exposure.  
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With respect to the human situation, where stressful life events have been shown to 
significantly increase the risk for the development of depressive disorders later in life, the 
question of whether social stress during adolescence is able to induce long-term alterations 
of HPA system regulation is of particular importance. To address this question, we 
investigated physiological, neuroendocrine and behavioral parameters in aged, 15-month-
old animals (i.e. 12 months after the termination of the stress procedure), in order to 
determine potential persistent effects of chronic social stress during adolescence. As 
expected, most of the pronounced acute effects of the stress exposure had normalized and 
the two experimental groups showed a similar phenotype in many parameters. However, 
even after 12 months of living in a stress-free environment, animals previously subjected to 
chronic stress during adolescence markedly differed in some specific aspects of behavior 
and physiology from non-stressed controls. We still observed a remarkable decrease of MR 
mRNA expression in the hippocampus of previously stressed animals, closely resembling 
the situation directly at the end of the stress paradigm 12 months earlier. Further, behavioral 
parameters indicating aspects of anxiety-related behavior, such as head dips on the elevated 
plus maze (Fernandez, 1997) or locomotor adaptation in a novel environment were found to 
be significantly different between both groups. These data indicate that the profound 
challenge of social stress exposure during adolescence and early adulthood had persistent 
effects on the behavior of the animals even at an old age.  
Given their potential to modulate principal electrophysiological properties of limbic 
neurons, it becomes evident that glucocorticoids play important roles in modulating fear 
and anxiety-related behavior (for review: Korte, 2001). As the mechanisms by which 
corticosteroids exert their effects on behavior are often indirect by modulating particular 
sets of neurons or neurotransmitter systems, contrasting effects of corticosteroids on fear, 
anxiety and depressed mood have been described. Aspects of fear and anxiety are affected 
differentially by the occupation of the MR or GR at different phases of the stress response. 
What might be the impact of persistent mineralocorticoid receptor down-regulation for the 
pathophysiology of stress-related psychiatric disorders? The cumulative evidence makes a 
strong case implicating corticosteroid receptor dysfunction in the pathogenesis of affective 
disorders (Neigh and Nemeroff, 2006; Holsboer, 2000). In this context, the observation that 
antidepressant treatment in rodents increases levels of hippocampal MR (Reul et al., 1993) 
and that MR receptor antagonism is unfavorably influencing the response to 
antidepressants, point to an important role of central MR in mediating antidepressant 
response (Holsboer, 1999). Persistent down-regulation of hippocampal MR mRNA in our 
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paradigm 12 months after cessation of the social stress exposure could therefore represent 
such a stable, stress-induced individual vulnerability factor, which in humans may 
predispose to the development of affective disorders later in life (Brunson et al., 2001). 
There are several potential explanations for the persistence of the chronic stress effects. 
Epigenetic modifications of DNA promoter regions have recently been shown to be 
modified by environmental influences, resulting in persistent changes of gene expression. 
Weaver and colleagues demonstrated that high licking and grooming behavior of rat 
mothers reduced the DNA methylation of a specific region of the GR promoter, which 
resulted in an altered GR expression and subsequently in physiological and behavioral 
changes (Weaver et al., 2004). A similar mechanism of action could also be postulated for 
the observed long-term effects of chronic stress exposure during adolescence, although 
there is so far little direct evidence for epigenetic programming in adult animals. 
Alternatively, chronic stress exposure might have resulted in structural changes in specific 
brain regions, possibly affecting neuronal number, dendritic branching or spine density. All 
of these structural parameters have previously been shown to be affected by high levels of 
glucocorticoids and could be responsible for long-term changes in behavior or function 
(Magarinos et al., 1988; Kleen et al., 2006). 
The observation that consequences of chronic stress during adolescence persist to late 
adulthood in animals is also important with regard to human studies that relate early trauma 
or adverse experiences with long-term effects (Heim and Nemeroff, 2001). It is well 
documented, that trauma during early life including puberty, like physical or sexual abuse, 
or life events, enhance the individual risk to develop affective disorders like depression in 
adulthood (McCauley et al., 1997). Genetic predisposition combined with experiencing 
early adverse events in vulnerable phases of development may both shape the individuals’ 
susceptibility to subsequent stressors and hence lead to manifestation of a disease.  
In contrast to other animal models revealing persistent effects of early postnatal stress, such 
as maternal separation of the pups (Plotsky and Meaney, 1993), we are able to show for the 
first time relevant long-term consequences of social stress that the animals were exposed to 
during adolescence. Maternal separation is usually performed in the neonatal phase (day 2-
15) during the stress-hyporesponsive period in which HPA system regulation is markedly 
different from stress hormone regulation in the adult animal (Levine, 2001). As in our 
model chronic stress takes place between days 28 and 81 of the animals’ life (i.e. in 
adolescent / adult animals), our data might be of particular relevance for the human 
situation with respect to the pathophysiology of stress-related psychiatric disorders. 
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Epidemiological studies clearly show, that stress alone is not sufficient to result in the 
manifestation of a disease. In many of the neuroendocrine and behavioral parameters we 
assessed at an old age we observed a trend, which probably did not reach the level of 
significance due to a high variability in the group. One might speculate that only a sub-
population of the previously stressed animals are largely and persistently affected by the 
stress exposure due to their specific genetic makeup, while other animals "recover" and are 
not at an enhanced risk for disease. As with the here applied chronic stress model it is 
feasible to subject a large number of animals to the stressful situation, future studies will 
have to focus on the individual differences between chronic stress animals in terms of the 
magnitude of persistent effects and their interaction with genetic vulnerability of the 
individuals. Furthermore, it will be interesting to study the possible pharmacological 
modification of persistent effects of chronic stress experiences.  
In summary, the application of chronic social stress during adolescence exerted robust 
immediate effects on HPA axis activity, gene expression, and anxiety-related behavior. 
These data support our previous findings and point to the high face, construct and 
predictive validity of this novel animal model for chronic social stress (Schmidt et al., 
2007). In addition, persistent effects of the chronic social stress could be detected in aged 
animals one year after stress termination. With respect to the postulated causal relationship 
between chronic stress and the development of human affective disorders, these data are the 
basis to study the underlying neurobiological mechanisms in detail. A better understanding 
of those pathophysiological mechanisms, in turn, will contribute to the development of 
novel, innovative, antidepressant drugs in the future. 
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3. Lasting consequences of chronic stress during adolescence on  
 cognition 
 
Cognitive dysfunction is known to play a pivotal role in a variety of diseases including 
major depression and anxiety disorders and there is evidence that cognitive impairment 
may in fact underlie many of the affective symptoms (Anisman and Matheson, 2005; 
Mathews and Mackintosh, 1998). On the other hand, late-onset depressive symptoms can 
often be a predrome of cognitive decline and represent early manifestations of memory 
disorders (Steffens et al., 2006; Charney et al., 2003). Sustained elevated glucocorticoid 
levels, resulting from a hyperactive HPA axis, have been hypothesized to represent a risk 
factor for both depressive disorders and cognitive impairment. 
Unlike brief periods of stress, which are rather thought to enhance cognition (Lupien et al., 
2007; McEwen and Sapolsky, 1995; McEwen, 1999; Shors et al., 1989; de Kloet et al., 
1998), chronic stress may be very detrimental and constitutes a key risk factor for diseases 
that affect memory performance. Permanently increased circulating cortisol levels could be 
associated with impairment in various cognitive domains like attention, perception and 
memory as well as reduced hippocampal volume (Newcomer et al., 1999; Jameison and 
Dinan, 2001).  
There are several animal models that try to relate the impact of stressors during different 
stages of life with cognitive decline in late adulthood or senescence. Brunson and 
colleagues could show that chronic early life stress (i.e. post natal day 2-9) resulted in 
selective, severe impairment in spatial and object recognition memory in middle-aged but 
not young adult rats. The process of cognitive decline therefore seems to be progressive, 
induced by the early aversive experience (Brunson et al., 2005). In adult rats, repeated 
social defeat affected neurophysiological aspects of hippocampal functioning reflected in 
LTP and LTD up to nine months following defeat (Van der Harst, 2003; Buwalda et al., 
2005). Also exposure to social stress during adulthood has adverse effects on memory as 
shown by Bodnoff and colleagues, who stressed rats for six months from ten months of age 
on, resulting in impairments in spatial memory detected by using the Morris water maze 
task (Bodnoff et al., 1995). In adult mice, both learned helplessness or chronic mild stress 
have been shown to result in spatial memory impairment in the Morris water maze (Song et 
al., 2006), although no lasting effects of the stress procedures were described. 
Another very important and often overlooked phase in life is the adolescent period. During 
this time of physical and sexual maturation, the brain is in a state of high plasticity, but also 
high vulnerability (McCauley et al., 1997). To study this critical life period, we have 
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recently developed a novel mouse paradigm for chronic social stress during adolescence 
and young adulthood, which closely resembles the human situation of social stress in terms 
of construct, face and predictive validity (Schmidt et al., 2007). Using this paradigm, which 
is based on the creation of a highly unstable social environment, we recently demonstrated 
long-lasting effects of stress exposure on neuroendocrine and behavioral parameters 12 
months after cessation of the stressor (see chapter 3). However, while various persistent 
effects of this novel stress paradigm are already described, there are no data available on 
effects of cognition and memory. 
In the current study, we investigated the long-term consequences of chronic social stress 
during adolescence on cognitive performance in 15-month-old animals. Further, we 
correlated the behavioral findings with electrophysiological and neurogenetic parameters 
involved in memory processes, in order to probe the molecular and physiological basis of 
the observed phenotype. 
  
Experimental design 
Experiment 1  
In order to assess memory performance in aged mice, a total of 40 mice (20 chronically 
stressed and 20 control animals) were used. After the chronic stress period all animals were 
separated and since the kept in single housing. 12 months after cessation of the stressor, at 
the age of 15 months, all animals were subjected to cognitive testing. Half of the mice (10 
control and 10 chronic stress animals) were tested in the Y-maze and the social 
discrimination task, the second half in the object recognition test and the Morris water 
maze. After testing, all animals were sacrificed under basal conditions and their brains were 
removed and kept frozen for gene expression analyses via in situ hybridization.   
 
Experiment 2 
In a subsequent experiment a second batch of mice was subjected to the chronic social 
stress paradigm and afterwards kept in single housing till the age of 15 months, analogously 
to experiment 1. The brains of 10 chronic stress and 10 control animals were dissected and 
one hemisphere was used immediately for electrophysiological recordings to assess 
potential alterations in hippocampal long-term potentiation (LTP). The other hemisphere 
was frozen and kept at -80 °C. 
 
Results 
Results 
Experiment 1 
Behavioral data 
To asses potential alterations in cognitive performance due to early chronic stress exposure, 
we tested the animals at an old age in relevant learning and memory tasks. In the social 
discrimination test, the animals of the control as well as of the stress group explored the 
novel female significantly longer compared to the familiar one, suggesting an intact social 
memory. No differences between both groups were detected at an intertrial interval of one 
hour (t-test, p=0.758). The same holds true for the object recognition test, where both 
groups explored the novel object significantly more often and longer compared to the 
known object but did not differ from each other in exploration times (t-test, p=0.365), 
indicating an intact object recognition memory. In the Y-maze, at an intertrial interval of 
one hour the animals of the stress group explored the additional plus arm significantly less 
often compared to controls (t-test, p<0.05), suggesting an impairment in the hippocampus-
dependent spatial memory (figure 15A). This finding could be confirmed by the results of 
the Morris water maze. Both groups were able to reduce their needed time to locate the 
submerged platform on successive trials on the first two test days. However, on day three, 
the animals of the stress group required significantly longer distances and latencies to 
escape onto the submerged platform (overall condition effect revealed by ANOVA with 
repeated measures: (F(2, 57) = 3.207 (p<0.05)), post-hoc significant on day 3 for all trials) 
(figure 15B). 
 
Figure 15: (A) Y-maze: long-term effects of chronic stress on the time exploring the additional plus arm. (B) 
Morris water maze: long-term effects of chronic stress on the time spent before locating a submerged 
platform. control = C; chronic stress = S; N = 10 per group. * significant from control group, p<0.05 
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Neurogenetic data 
We analyzed basal gene expression of relevant neurotransmitter receptors involved in 
learning and memory in the hippocampus 12 months after stress termination. For the 
AMPA 1 receptor subunit GluR1 we could detect a significant increase in the GluR1 
mRNA in the CA1, the CA3 and the dentate gyrus region of the hippocampus in the 
chronic stress group (t-test, p<0.05) (figure 16A). For NMDA1 mRNA no differences were 
found between both groups and for GABA A mRNA we could detect a significant decrease 
in the dentate gyrus (p<0.05) as well as a statistical trend in the CA1 region (p<0.06) 
(figure 16B). Furthermore, we determined the mRNA expression levels of the 
neurotrophine BDNF in the Ca1, CA3 and DG region of the hippocampus as well as in the 
cortex. In previously stressed animals a significant decrease of BDNF mRNA could be 
detected in all of these regions (t-test, p<0.05) (figure 17). 
 
 
Figure 16: Long-term effects of chronic stress on neurogenetic data: mRNA expression of hippocampal (A) 
GluR1 and (B) GABA A receptor subunits. N = 12 per group. * significant from control group, p<0.05 
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Figure 17: Long-term effects of chronic stress on BDNF mRNA expression levels in the hippocampus.  
N = 12 per group. * significant from control group, p<0.05 
 
Experiment 2 
Electrophysiology 
To assess whether impairments in cognitive performance due to early chronic stress 
exposure coincided with alterations in synaptic plasticity in the CA1 region of the dorsal 
hippocampus, we studied long-term potentiation in the Schaffer collateral-commissural 
pathway in acute brain slices from control and stressed animals. After induction of LTP by 
high-frequency stimulation, slices of previously stressed mice showed a significantly 
weaker LTP than control littermates for at least 60 minutes after high-frequency stimulation 
(control: 194.3 ± 15.5%, n = 18; stressed: 146.4 ± 9.8%, n = 19; t-test, p<0.05) (figure 18).  
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Figure 18: Long-term effects of chronic stress on long-term potentiation in the hippocampal CA1 area.  
N = 10 per group. * significant from control group, p<0,05 
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Western blots 
Chronic stress might have induced adaptational changes within various neurotransmitter 
systems involved in learning and memory. Therefore, we analyzed the hippocampal region 
for the protein expression levels of the NMDA-receptor subunits NR2A and NR2B. 
Western blot analyzes revealed no difference in the protein expression levels of NR2A (t-
test, p=0.885) (figure 19A), while the NR2B subunit seemed to be increased in previously 
stressed animals (figure 19B). However, due to large individual differences in the stress 
group this effect did not reach statistical significance (t-test, p<0.1). 
 
 
 
 
 p<0,1 
                                 
         C            S       C          S 
Figure 19: Long-term effects of chronic stress on neurogenetic data. Hippocampal protein levels of (A) 
NMDA receptor 2A and (B) NMDA receptor 2B. N = 10 per group. * significant from control group, p<0.05 
 
Discussion 
Our current data demonstrate for the first time effects of a chronic social stress exposure 
during adolescence on memory performance during aging. One year after cessation of the 
chronic social stress regimen, a substantial impairment of spatial memory could be detected 
in the previously stressed animals compared to controls. These findings were further 
supported by electrophysiological and neurogenetic data, indicating the hippocampal 
formation as main target for these long-term consequences of chronic social stress. 
By applying various memory tests in 15-months old mice, only differing in their stress 
history during adolescence, we investigated learning and memory performance of different 
memory domains. These tests revealed that previously stressed mice displayed a memory 
deficit specific for spatial memory, while other memory domains such as social or object 
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recognition memory seem not to be differentially affected. As the hippocampal formation 
has previously been shown to be specifically involved in spatial memory processes (Squire, 
1992; Squire and Zola-Morgan, 1991; Zola-Morgan et al., 1994; Nadel, 1991; Duva et al., 
1997; Jarrard, 1993; O'Keefe and Nadel, 1978), we focused our further functional analysis 
on this structure. In fact, for memory performance in social or object recognition tasks key 
roles of non-hippocampal structures including the amygdala, the rhinal cortex and the 
prefrontal cortex have been implicated (Otto and Eichenbaum, 1992; Mishkin and Murray, 
1994; Mumby and Pinel, 1994). Using electrophysiological recordings, we could detect 
reduced in vitro LTP in the hippocampal CA1 region of stressed animals 12 months after 
cessation of the stressor. Based on the suggested involvement of LTP in memory formation, 
these data imply a direct electrophysiological correlation with our behavioral data. This 
finding is in line with other studies that associated behavioral stress with an impairment in 
the induction of long-lasting activity-dependent changes in synaptic efficacy, such as LTP, 
later in life (Brunson et al., 2005; Artola et al., 2006; von Frijtag et al., 2000; Gerges et al., 
2004; Diamond et al., 2004). Thus, it seems likely that stressful early life experience during 
adolescence lastingly affects hippocampal function.  
There are at least two main possibilities of how these differences in hippocampal function 
can be mediated. First, it is possible that differences in transcription or post-transcriptional 
regulation of neurotransmitter systems involved in learning and memory processes are 
permanently altered. Second, long lasting structural changes of hippocampal dendritic 
branching or dendritic spine number or number of neurons could result in a different 
hippocampal function. To address the first possibility, we investigated expression levels of 
several neurotransmitter receptor subunits, which are known to play a key role in 
hippocampal learning and memory. Indeed we observed significant differences between 
previously stressed and control animals in hippocampal mRNA expression levels in terms 
of a GluR1 up-regulation and GABA down-regulation. Further we detected an increase in 
hippocampal NR2B protein levels in previously stressed animals, albeit due to a large 
individual variation in the stress group this increase was not statistically significant. As the 
animals of the chronic stress group had shown reduced in vitro LTP, based on literature 
reports from animal studies one would rather assume the converse regulation pattern. 
Particularly an over expression of NR2B is strongly associated with enhanced learning 
abilities in mice and rats (Tang et al., 1999). However, we should keep in mind that in those 
studies the animals used were younger in age which contrasts the present study, which was 
conducted with 15-month-old animals. This difference might be an important detail as it is 
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currently not known how a general state of over excitation resulting from a persistently 
increased expression of excitatory glutamate receptors and a reduced number of GABA 
receptors, potentially leading to increased intracellular calcium levels among other changes, 
impacts the CNS and possibly leads to a state of neuronal stress and finally excitotoxicity. 
Also in patients with moderate or severe cognitive impairment a reduction in GABA A 
mRNA had been demonstrated, which occurs probably very early in the progression of 
Alzheimer’s disease (Rissman et al., 2004). In addition to the above mentioned receptors, 
downstream second messenger cascades regulating the activity of relevant kinases and 
phosphatases are highly involved in cognitive processes and alterations in their efficacy 
might also severely contribute to the observed reduction in in vitro LTP, independently 
from the receptor subunit expression patterns. 
What could be the mechanism, by which the gene expression of these receptor genes is 
permanently altered due to the chronic stress exposure during adolescence? We previously 
reported lasting differences in glucocorticoid and mineralocorticoid receptor expression 
levels 12 months after stress exposure (Sterlemann et al., 2007). As both receptors are 
highly expressed in the hippocampus and act as transcription factors, they could lastingly 
influence the expression of target genes, including systems involved in memory function. 
Interestingly, both MR and GR are known to be involved in information processing and 
modulate hippocampal circuits that underlie complex cognitive function such as spatial 
learning. Indeed, their role in learning and memory could be well established by conducting 
studies using knockout lines or the administration of selective agonists or antagonists (Oitzl 
and de Kloet, 1992; Sandi and Rose, 1994; Tronche et al., 1999; Oitzl et al., 2001). 
Depending on the differential activation of MR and GR by corticosterone, LTP can be 
blocked or induced, suggesting MR and GR to be important determinants of synaptic 
plasticity and finally learning and memory (Joels and Krugers, 2007; de Kloet et al., 2002). 
In addition to the genomic actions of these receptors, the MR has recently also been 
implicated in fast, non-genomic glucocorticoid actions (Karst et al., 2005), which might 
also influence memory acquisition or retrieval. An alternative or additional possibility for 
the lasting changes in gene expression observed 12 months after chronic stress exposure are 
epigenetic modifications of the DNA. These modifications have recently been shown to be 
evoked and varied by environmental influences and result in enhanced or diminished 
transcription rates of specific genes (Agrawal, 2001; Weaver et al., 2004). 
As mentioned above, structural changes of the hippocampal neurons could underlie the 
observed differences in memory function. Dendritic atrophy in terms of less branch points 
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and/or reduced dendritic length (Brunson et al., 2005; Conrad et al., 1996; Magarinos et al., 
1996; McKittrick et al., 2000) as well as impaired neurogenesis have been observed 
following chronic stress in different species and across numerous paradigms (Joels et al., 
2007; Mirescu and Gould, 2006). Although the structural analysis of the hippocampus in 
aged mice subjected to chronic stress during adolescence is beyond the scope of this study, 
our observation of pronounced differences in BDNF expression suggest the possibility of 
structural parameters underlying the functional deficits in previously stressed animals. 
Belonging to the family of the neurotrophines, which are strongly involved in neuronal 
survival and differentiation, BDNF is known to improve memory and its down-regulation 
in the hippocampus may be one major component causing LTP impairment. Studies using 
BDNF knockout mice proved BDNF being responsible for the induction and probably also 
maintenance of LTP (Figurov et al., 1996; Korte et al., 1995; Korte et al., 1996) that can be 
rescued by the application of exogenous BDNF in vitro (Patterson et al., 1996) and in vivo 
(Radecki et al., 2005). Aleisa and colleagues also observed reduced hippocampal BDNF 
levels and impaired LTP in the CA1 region in adult rats subjected to chronic psychosocial 
stress, underlining the strong detrimental impact of this type of stressor, leading to changes 
in neurotrophine levels and finally impaired cognitive function (Aleisa et al., 2006). 
In summary, our results clearly demonstrate that chronic social stress exposure during the 
adolescent period of mice can result in long-term alterations of spatial memory 
performance, which are detectable even one year after the stress regimen was terminated. 
These behavioral differences are accompanied by differences in electrophysiological 
properties as well as a differential gene expression of genes involved in hippocampal 
memory function. These data underline the importance of the adolescent and young adult 
period as a critical transitory phase with potential for both adaptive and maladaptive 
outcomes in adulthood and indicate pathophysiological mechanisms that may contribute to 
the adverse long-term effects of chronic social stress on memory function. 
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4. Long-term consequences of chronic stress during  
 adolescence on body fat distribution 
 
In modern societies obesity is a seriously increasing public health issue. When defined by a 
body mass index of 30.0 or higher according to the National Health and Nutrition 
Examination Survey (NHANES9, its prevalence has increased by a twofold over the last 20 
years, affecting about 30% of the US population (Tamashiro et al., 2007; Hu et al., 2004) 
with no trend for a decline (Hedley et al., 2004). The incidence of obesity is strongly 
associated with arterial hypertension and metabolic abnormalities as glucose intolerance, 
insulin resistance, increased visceral fat and dyslipidemia that, when clustering together, are 
referred to as metabolic syndrome (Day, 2007). These follow-on diseases associated with 
obesity impose a significant economic burden on individuals, families and public health 
systems (Ogden et al., 2007). 
Chronic stress has been shown to represent a risk factor for obesity and the metabolic 
syndrome (Seematter et al., 2004) that adds to increased energy consumption and decreased 
physical activity in modern society. For instance chronic work stress was found to correlate 
with obesity in humans (Brunner et al., 1997), doubling the risk for metabolic syndrome 
(Chandola et al., 2006). A causal relation between hypothalamic-pituitary-adrenal (HPA) 
axis activity, obesity and specifically accumulation of visceral fat has been proposed 
(Rosmond and Bjorntorp, 1998). In a recent prospective study, Branth and colleagues 
demonstrated that in originally non-obese young men long-term stress induced abdominal 
obesity and symptoms of metabolic syndrome with a delay of about five months (Branth et 
al., 2007). Beside this epidemiological evidence for a linkage between stress exposure and 
metabolic changes in humans, various studies in animal models suggest that stress affects 
feeding behavior (Carr, 2002), alters caloric intake (Dallman et al., 2003) and changes body 
weight and fat content (Tamashiro et al., 2007).  
A number of links exist between disturbed metabolic homeostasis and affective disorders. 
Next to the metabolic syndrome, chronic stress also represents a major risk factor for the 
development of affective disorders (de Kloet et al., 2005) and depressive patients more 
often suffer from general obesity, metabolic syndrome (Faith et al., 2002; Stunkard et al., 
2003; Heiskanen et al., 2006) and cardiovascular complications (Perlmutter et al., 2000). 
Further HPA axis dysregulation can frequently be observed in major depression (Holsboer, 
2000), and particularly patients with hypercortisolemia develop visceral obesity (Weber-
Hamann et al., 2002). Therefore, a common pathophysiological basis of both affective 
disorders and the metabolic syndrome has been postulated (Kyrou and Tsigos, 2007). 
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Additionally, long-term effects of previous depressive episodes and psychosocial stress on 
the risk to develop metabolic syndrome or obesity have been concluded from clinical 
observations (Heiskanen et al., 2006; Raikkonen et al., 2007). 
In the light of limited data explaining the pathophysiology of the delayed or prolonged 
impact of chronic stress on metabolism and body composition, preclinical studies using 
animals models for chronic stress in combination with non-invasive magnetic resonance 
imaging (MRI) are of particular use and can help to further elucidate the underlying 
mechanisms. The first goal of this study was to probe if chronic social stress applied during 
the adolescent period of mice has an effect on body fat distribution at an older age, i.e. 12 
months after cessation of the stress regimen. Given the current opinion that restoration of 
the HPA axis function represents a common pathway of antidepressant drug action (Ising et 
al., 2007) and normalization of the HPA system has been shown to be a prerequisite for 
stable remission (Zobel et al., 1999; Holsboer, 2000), we further hypothesized that lasting 
effects of chronic stress on metabolic parameters may be prevented by a simultaneous 
chronic treatment with an antidepressant throughout the stress period. 
 
Experimental design 
Three different groups were used: (1) control animals, (2) untreated chronic stress animals 
and (3) chronic stress animals treated with the SSRI paroxetine (see drugs). Three weeks 
after the start of the chronic stress procedure, 12 animals of the chronic stress group were 
treated with the antidepressant paroxetine, while 20 animals remained untreated. At the 
start of the drug treatment animals of the chronic stress group showed clear symptoms of 
stress. Drug treatment continued for 4 weeks until the end of the stress exposure. Control 
animals (N = 22) were not treated with paroxetine. At the end of the stress procedure 
animals from all groups were separated and single housed. After 12 months of single 
housing with no further intervention, all animals were sacrificed under basal conditions. 
 
Results 
At the time of testing the three groups studied (controls, chronic stress and chronic stress + 
paroxetine) did not differ in mean body weight, or for visceral fat or subcutaneous fat 
content only. When analyzing the visceral-to-subcutaneous fat ratio we found significant 
group differences (F(2,48) = 4.073 (p<0.05)) (figure 20B). Post-hoc comparisons located 
the effect to the untreated stressed animals (1.571 ± 0.56) that differed significantly from 
Results 
controls (1.21 ± 0.314; p<0.05) and paroxetine treated mice (1.23 ± 0.366; p<0.05). No 
difference was found between the control group and the paroxetine treated chronic stress 
animals (p = 0.93).  
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Figure 20: (A) Axial slice through the mouse abdomen. Fatty tissue is bright. A region-of-interest is indicated 
segmenting the image into visceral and (sub-)cutaneous compartments. (B) Visceral to subcutaneous fat ratio. 
Mean values for each group are indicated. * significant from control group. + significant from paroxetine 
treated chronic stress group. 
 
Discussion 
In this study we demonstrate for the first time long-lasting effects of early life chronic 
stress experience on body fat composition later in life in an animal model. At the age of 15 
months, previously stressed animals showed a marked increase in the visceral to 
subcutaneous fat ratio. Intriguingly, these effects are very long lasting and observed months 
after the termination of the stressor under stress-free conditions. Our current results are 
further corroborated by findings of lasting effects of chronic stress in terms of long-term 
behavioral, neuroendocrine and neurogenetic alterations (Sterlemann et al., 2007). After 
one year of recovery baseline corticosterone secretion was not altered anymore, but we 
could still observe a decreased expression of hippocampal mineralocorticoid receptors. 
Thus, the chronic stress exposure during adolescence has permanently altered the 
expression of relevant genes in specific brain regions.  
Which mechanism could account for the long-term effects of chronic social stress on body 
fat composition? It is easily conceivable that in addition to central effects chronic stress 
exposure has also affected peripheral glucocorticoid signalling, since we had observed a 
long lasting elevation of morning corticosterone levels and a flattened circadian rhythm in 
the animals of the chronic stress group (Schmidt et al., 2007). Especially a persistently 
altered expression of peripheral glucocorticoid receptors as a result of the long-term altered 
corticosterone levels is likely, which in turn might cause changes in downstream protein 
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expression or altered enzymatic activities. Mazusaki and colleagues could show that a 
transgenic mouse line which locally over expresses 11β hydroxysteroid dehydrogenase type 
1 (11β HSD-1), an enzyme which catalyzes the regeneration of active glucocorticoids from 
inactive keto-forms, in adipose tissue displayed increased adipose levels of corticosterone 
and developed visceral obesity. As those mice also exhibited pronounced insulin-resistant 
diabetes and hyperlipidemia among other symptoms, the authors proposed that increased 
adipocyte 11β HSD-1 activity may be a common molecular etiology for visceral obesity 
and the metabolic syndrome (Masuzaki et al., 2001). This adipose tissue specific increase in 
11β-HSD1 activity has recently be shown to be a common symptom in obese humans and 
rodents (Seckl and Walker, 2004). Thus, an increase in the activity of 11β HSD-1 may 
possibly also result from chronic stress exposure, which in our paradigm particularly is 
experienced in the highly adaptive and vulnerable period of adolescence and young 
adulthood. In addition, there are most likely numerous other changes in gene or protein 
expression of central or peripheral factors by chronic stress, determining the visceral fat 
content either directly or by influencing central body fat regulation, e.g. by the 
hypothalamus. As the animals of the chronic stress group who had received the 
antidepressant paroxetine (SSRI) during the stress phase did not show the increase in the 
visceral to subcutaneous fat ratio, one could rather propose central mechanisms being 
responsible for the changes in metabolic homeostasis. This hypothesis is supported by our 
earlier findings, where chronic treatment with paroxetine normalized several other centrally 
regulated HPA and behavioral parameters, like increased morning corticosterone levels, 
decreased hippocampal MR and GR expression and an increase in anxiety related behavior. 
Thus, there might exist converging underlying mechanisms that are responsible for both the 
development of depression and metabolic syndrome.  
These experimental results have strong implications for clinical medicine at the crossing of 
neuroendocrinology, inner medicine and psychiatry. First, the findings help to bridge the 
gap between obesity and the metabolic syndrome which tend to appear in adulthood, and 
earlier exposure to chronic stress. Early life stress has for long been investigated mainly as 
risk factor for later development of affective disorders and other psychiatric conditions (de 
Kloet et al., 2005), but not for sustained or delayed metabolic changes that lack a 
behavioral correlate in the first place. Only in the last years, epidemiological evidence has 
emerged showing that depressive symptoms or very stressful life events increase the risk to 
develop type II diabetes and metabolic syndrome later in life (Raikkonen et al., 2007; 
Engum, 2007) and that major depression is predictive of long-term body weight variability 
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independent of medication effects (Hasler et al., 2005). Moreover, rather than clinical 
depression as such, hypercortisolemic states have been shown to aggravate the risk to 
disbalance metabolic homeostasis (Vogelzangs et al., 2007; Duclos et al., 2005) when 
analyzed cross-sectionally, suggesting a pathophysiological link. To the best of my 
knowledge, no clinical data have linked adolescent HPA axis profiles to metabolic data 
later in life. With regard to a translation to clinical medicine, our results should foster such 
longitudinal cohort studies. It should be noted that obesity itself is being recognized a 
chronic inflammatory state that through signalling of adipocytes may trigger further 
metabolic complications (Kyrou and Tsigos, 2007). Therefore, mechanisms such as 
epigenetic changes that adhere a metabolic risk situation once the stressor has ceased are of 
particular interest. 
A second clinical implication arises from the results of the pharmacological intervention. 
The reconstitution of normal HPA axis signalling has been identified as a biological marker 
of successful antidepressant pharmacotherapy that also implicates a better clinical 
prognosis for a patient (Ising et al., 2007). Although premature at this stage, it may be 
speculated that early pharmacological targeting of the stress hormone system in affective 
disorders may also prevent later metabolic complications. Future work also needs to clarify 
if therapeutic consequences should be extended from psychiatrically manifest disease to 
situations of endocrinologically measurable chronic stress. With regard to their clinical 
implications, the data of this study are limited as visceral obesity was used as surrogate for 
metabolic disturbance while other parameters were not available. 
Thus, stressful experiences during crucial life phases such as adolescence and young 
adulthood seem to highly affect body composition and therefore the risk for disease later in 
life. These data further support and confirm the sparse human data of chronic stress being a 
risk factor for altered body fat composition (Branth et al., 2007). 
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5. Rimonabant treatment during chronic stress: behavioral,  
 neuroendocrine and metabolic consequences 
 
The CB1 receptor is densely expressed in several brain regions including areas controlling 
emotional processes like the limbic system (Tsou et al., 1998) and there is substantial 
evidence proving the endocannabinoid system to be highly involved in the control of 
emotional behavior and mood (for review: Pacher et al., 2006). However, there are many 
contradictory findings on the specific way of action. On the one hand endogenous 
cannabinoids and the administration of exogenous cannabinoids like Δ9-THC were found 
to reduce anxiety-like behavior (Kathuria et al., 2003; Berrendero and Maldonado, 2002; 
Valjent et al., 2002) and on the other hand to enhance anxiety-related behavior in relevant 
test paradigms (Arevalo et al., 2001; Onaivi et al., 1990). These differences might in part 
derive from a dose dependency, but also test conditions and strain differences seem to have 
high impact on the behavioral phenotype. Also for selective CB1 antagonists, like for 
example rimonabant (SR141716A), the picture remains unclear. While in many studies an 
anxiogenic phenotype was described (Navarro et al., 1997; Arevalo et al., 2001), in some 
rodent anxiety and depression models the administration of rimonabant lead to anxiolytic 
and antidepressant-like effects (Rodgers et al., 2003; Akinshola et al., 1999; Haller et al., 
2002). These inconsistent findings were more recently suggested to be due to the fact that 
cannabinoids exert their effects in a bidirectional manner: Via the CB1 receptor, resulting 
in an anxiolytic effect, and via a novel neuronal cannabinoid receptor, resulting in an 
anxiogenic effect (Haller et al., 2002; Rodgers et al., 2005). Accordingly, CB1 receptor 
knockout mice display generally marked increases in anxiety-related behavior compared to 
wild types (Haller et al., 2002; Maccarrone et al., 2002). Thus, as already stated by Rodgers 
and colleagues, to better characterize the effects of CB1 receptor blockade on emotional 
processes more ethologic-orientated techniques need to be employed (Rodgers et al., 2003). 
There are a series of studies that proved the endocannabinoid system to be involved in the 
modulation of the HPA axis, which is a major regulator of the stress response and has a 
crucial role in mood regulation. Thus, the potential functional relationship between the 
effects of endocannabinoids on the HPA axis and anxiety is under extensive research 
(Manzanares et al., 2004; Murphy et al., 1998; Patel et al., 2004; Barna et al., 2004). In a 
large-scale study, for instance, Griebel and colleagues investigated the effects of acute or 
chronic rimonabant treatment in several animal models of anxiety in rats, mice and gerbils. 
As one major finding in mice they could demonstrate a clear improvement of stress 
symptoms after chronic rimonabant treatment during a chronic unpredictable stress regimen 
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in terms of a reduced anxiety- and depression-like phenotype (Griebel et al., 2005). 
However, they did not investigate potential lasting effects of rimonabant on HPA function 
and behavior. 
The CB1 receptor and the endocannabinoids are also known to be present in brain regions 
controlling food intake and are proposed to be involved in the modulation of feeding 
behavior (Cota et al., 2003; Mechoulam and Fride, 2001; Howlett, 2002). By performing 
CB1 antagonists studies, central orexigenic effects of the endocannabinoids could be 
revealed (Colombo et al., 1998; Freedland et al., 2000). Accordingly CB1 knockout mice 
are usually lighter and leaner compared to their wild type littermates (Cota et al., 2003). 
However, so far only little is known about the interaction of the endocannabinoid system 
with the numerous other neuropeptides involved in the regulation of feeding and energy 
balance. Gradually first evidence for a functional relationship between the endocannabinoid 
system and central metabolic regulators can be manifested: Leptin, which is suggested to be 
the key mediator of the anorexogenic drive, has been shown to lower central hypothalamic 
endocannabinoid levels (Di Marzo et al., 2001), while ghrelin, which is orexigenic, 
potentially acts by increasing endocannabinoid production in the hypothalamus (Tucci et 
al., 2004). To gain a comprehensive picture, though, further research is indispensable. Of 
late, the CB1 antagonist rimonabant is used successfully as an antiobesity drug and most 
likely exerts its function by affecting the HPA axis (Manzanares et al., 1999). Interestingly, 
both depression and obesity share a dysregulation in HPA axis activity and several 
antiobesity as well as antidepressant drugs affect HPA axis function (Bornstein et al., 
2006). Thus, to better understand the role of the endocannabinoids in modulating the HPA 
axis would be of great value. 
To further elucidate this interaction, in this study we investigated the impact of chronic 
CB1 antagonist treatment on our recently validated chronic social stress paradigm in mice. 
The stress is applied during the adolescent period of the animals, a phase where the brain is 
in a state of high plasticity, but also high vulnerability (McCauley et al., 1997). In the first 
part of this study we investigate the effect of chronic treatment with the CB1 receptor 
antagonist rimonabant (SR141716A) on the medium-term consequences of chronic stress 
(i.e. 7-15 days after stress cessation) on physiological, neuroendocrine and behavioral 
parameters. In the second part of this study, we investigated the efficacy of chronic 
rimonabant treatment during the stress period in preventing potential long-term metabolic 
alterations resulting from chronic stress. Therefore we subjected control and previously 
stressed animals at the age of 6 and 12 months, i.e. 3 and 9 months after cessation of the 
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stressor, to an oral glucose tolerance test and glucose as well as insulin levels were 
determined. 
  
Experimental design 
108 mice were chronically stressed, while 40 control animals remained undisturbed with 
the same cage mates throughout the experiment. 3 weeks after the start of the chronic stress 
procedure, 52 animals of the chronic stress group were treated with the CB1 antagonist 
rimonabant (SR 141716A) for 28 days. At the start of the drug treatment animals of the 
chronic stress group showed clear symptoms of stress. After 7 weeks of continuous stress 
exposure all animals were separated and since then kept in single housing with no further 
drug treatment.  
 
Experiment 1: medium-term effects  
Tests were carried out 7-15 days after the last change in group composition. A subset of 16 
animals per group was used for neuroendocrine testing after 7 days of single housing. The 
fur state of the animals was rated by two independent researchers according to a 4-point 
scale (Mineur et al., 2003; Ducottet et al., 2003), with 1 as the best and 4 as the worst fur 
condition. On the next morning, the animals were decapitated under basal conditions.  
The remaining animals were tested in the following behavioral tests: open field (after 8-9 
days of single housing), novelty-induced suppression of feeding (after 10-11 days of single 
housing) and elevated plus maze (after 14-15 days of single housing).  
 
Experiment 2: long-term effects 
For the investigation of the long-term effects of chronic stress, a total of 30 (10 control, 10 
chronic stress and 10 chronic stress/rimonabant) 6- or 12-month-old animals were used for 
oral glucose tolerance testing. All animals were food deprived overnight from 17.00h till 
8.00h the next morning. At 8.00h one basal blood sample was taken by tail cut (Fluttert et 
al., 2000), followed by application via oral gavage of 3 mg/g bodyweight glucose dissolved 
in 250 μl water. Further blood samples were taken 30, 90 and 120 minutes after glucose 
administration again by tailcut. Glucose was determined immediately based on electronical 
sensor technology using a blood glucose meter (Ascensia Elite®, Bayer). For insulin blood 
samples were centrifuged and plasma was kept frozen until determination using a 
Lincoplex assay (LINCOplexTM, Linco research, Inc). 
Results 
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Experiment 1 
Physiological data 
Body weight was determined at the end of the chronic social stress and treatment. One-way 
ANOVA revealed a significant difference in body weight between the groups (F(2,144) = 
3.443 (p<0.05)) with the untreated stress animals being significantly heavier compared to 
rimonabant treated chronic stress animals. The mean body weight of control mice was in 
between both stress groups (table 4). The adrenal and thymus glands of 16 control, 16 
untreated chronic stress and 16 rimonabant treated chronic stress animals, which were 
sacrificed after seven days of recovery, were dissected and weighed. For both organs, 
ANOVA revealed a main effect of condition (adrenals: (F (2,39) = 10.982 (p<0.001)); 
thymus: (F (2,34) = 15.352 (p<0.001)) (table 4). Chronic stress resulted in a significant 
increase in adrenal weights. This effect was even worsened by rimonabant treatment during 
stress exposure (p<0.1). Thymus weight was significantly reduced in the untreated chronic 
stress group compared to control animals. Rimonabant treatment had neither ameliorating 
nor deteriorating effect.  
The fur condition of the animals was rated carefully by two independent observers 
according to a 4 point scale prior to blood sampling, with a higher number corresponding to 
a worse fur state. A significant deterioration of the fur state of both untreated and 
rimonabant treated chronically stressed animals compared to controls could be detected  
(F (2,143) = 23.498 (p<0.001)) (table 4).  
Table 4: Influence of rimonabant treatment during chronic social stress exposure on body weight, adrenal 
weight, thymus weight and fur state. * significant from control group, p < 0,05; + significant from chronic 
stress group, p<0.05; 
control chronic stress chronic stress 
+ rimonabant 
adrenal weight 
(mg/g bw) 
0.111 ± 0.009 0.141 ± 0.006* 0.167 ± 0.007*+
thymus weight 
(mg/g bw) 
1.268 ± 0.067 0.841 ± 0.034* 0.871 ± 0.072*
fur state  1.28 ± 0.08  2.15 ± 0.11*
 
 2,28 ± 0.1*
 
F-value p-value 
12,631  0,001 
12,929  0,001 
―  0,001 
38,546 ± 0,36 37,098 ± 0,43 3,443 <0,05 37,667 ± 0,46 body weight 
(g) 
 
 
 77
Results 
Neuroendocrine data 
Basal corticosterone plasma levels were measured after seven days of single housing. One-
way ANOVA revealed a statistical trend for corticosterone differences between the groups 
(F (2,44) = 2.869, (p<0.1)), with rimonabant treated stress animals having increased 
morning corticosterone levels compared to controls (p<0.1) (figure 21). Due to large 
standard deviations, no significant differences could be observed between the untreated 
chronic stress animals and the controls. 
 
Figure 21: Influence of rimonabant treatment during chronic stress exposure during adolescence on HPA axis 
function: Basal morning corticosterone levels after one week of recovery. N = 16 per group.  
 
Further, we analyzed basal gene expression of GR and MR mRNA in the hippocampus. For 
the GR, ANOVA revealed a significant effect of condition in the CA1 region (F(2,29) = 
5.214 (p<0.05)) and the dentate gyrus (F(2,29) = 5.539 (p<0.05) (figure 22A). Chronic 
stress significantly decreased GR mRNA expression in the these regions, which could be 
partly prevented by treatment with the CB1 antagonist rimonabant. In the PVN no 
differences in GR mRNA expression levels could be found. For hippocampal MR mRNA, 
ANOVA revealed a significant effect of condition (CA1: F(2,26) = 4.897 (p<0.05); CA2: 
F(2,26) = 5.338 (p<0.05); CA3: F(2,26) = 11.591 (p<0.001); DG: F(2,25) = 3.200 (p<0.1)) 
(figure 22B). The mRNA expression level of MR in chronic stress animals was 
significantly decreased in the CA3 area compared to control animals, a statistical trend 
could be observed in CA2 (p<0.1). Rimonabant treatment did not reverse this effect, but on 
the contrary caused a stronger down-regulation, resulting in a significant decrease 
compared to the control group in the CA1, CA2 and CA3 region. A statistical trend could 
be detected in the dentate gyrus (p<0.1). We also analyzed basal gene expression of CRH in 
the whole PVN and AVP mRNA in the parvocellular part of the PVN, but could not detect 
any differences between the groups after seven days of single housing. 
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B A 
Figure 22: Influence of rimonabant treatment during chronic stress exposure on (A) GR mRNA expression in 
the CA1 region and the dentate gyrus of the hippocampus and (B) MR mRNA expression in the CA1, CA2, 
CA3 region and the dentate gyrus of the hippocampus. N = 12 per group. * significant from control group, 
p<0.05 
 
Behavioral data 
To asses medium-term alterations in behavior due to chronic stress exposure we tested the 
animals in anxiety-related behavioral tests. We recorded the locomotor activity of the 
different groups in an open field test. As a measure of the animals’ adaptability to a novel 
environment, the distance traveled in the fifth minute of the test was subtracted from the 
distance traveled in the first minute, called locomotor adaptation. For this parameter, 
ANOVA revealed a main effect of condition (F(2,35) = 8.399 (p<0.005)) (figure 23A). 
Chronic stress resulted in a significant decrease of locomotor adaptation compared to 
controls (p<0.01). This effect could not be reversed by rimonabant treatment (p<0.005). 
The basal locomotor activity in the last 25 minutes of the open field exposure was not 
different between the groups (F(2,35) = 0.540, (p = 0.588)).  
Untreated chronically stressed animals also displayed an enhanced anxiety-related behavior 
in the novelty-induced suppression of feeding paradigm. Control animals initiated the 
feeding of a snack faster compared to previously stressed animals with the rimonabant 
treated chronic stress animals being in between. However, due to large variation in the 
stress groups, this effect was not significant (ANOVA: (F (2,34) = 1.709 (p = 0.197)) 
(figure 23B).  
In the elevated plus maze test a main effect of condition could be detected for the number 
of open arm entries (F(2,30) = 5.517 (p<0.05)) with untreated and rimonabant treated 
chronic stress animals exploring the open arms significantly less often compared to controls 
(p<0.05). Both groups also tended to spent less time on the open arm (F(2,30) = 3.041 
(p<0.1)) (figure 23C). The total distance traveled did not differ between the groups. 
 79
Results 
Further, control animals showed significantly more head dips compared to chronic stress 
animals (ANOVA: (F(2,30) = 9.737 (p<0.001)); post hoc p<0.005) (figure 23D), which is 
regarded one of the best parameters of anxiety in the elevated plus maze (Fernandez, 1997). 
Also this effect was not reversed by rimonabant treatment. 
 
Figure 23: Influence of rimonabant treatment during chronic social stress exposure on changes in anxiety-
related behavior. (A) Open field: Treatment effects on locomotor adaptation during the first 5 minutes. (B) 
Novelty-induced suppression of feeding: Treatment effects on the time till initiation of almond consumption. 
Plus Maze: Treatment effects on (C) time spent in the open arms and number of entries to the open arms and 
(D) on the number of head dips. control = C; chronic stress = S; chronic stress + rimonabant = S+R. N=12 per 
group. * significant from control group, p<0.05 
 
Experiment 2 
At the age of six month, i.e. after three months of recovery, glucose levels did not differ 
between the three groups at any time point of the oral glucose tolerance test (F (2,30) = 
1.19 (p = 0.32)) (figure 24A). For corresponding insulin levels ANOVA with repeated 
measures revealed a main effect of time (F(2,23) = 35.06 (p<0.001)) and condition (F 
(2,23) = 17.452 (p<0.001)) (figure 24B). Via post-hoc analysis we determined significantly 
lower insulin levels in previously rimonabant treated chronic stress animals compared to 
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controls and untreated chronic stress animals 30, 90 and 120 minutes after glucose 
administration (p<0.05). 
 
Figure 24: Influence of rimonabant treatment during chronic social stress exposure on long-term changes in 
glucose metabolism at the age of six months. Time course of (A) glucose levels during an oral glucose 
tolerance test and (B) corresponding insulin levels. N = 10 per group. * significant from control group, p<0.05 
 
Also at the age of 12 months, i.e. 9 months after cessation of the stressor, no differences in 
glucose levels could be observed between the three groups (F(2,29) = 1.58 (p = 0.225)) 
(figure 25A). For insulin we detected a main effect of time (F(2,26) = 26.95 (p<0.001)) and 
condition (F(2,26) = 9.259 (p<0.001)) with the rimonabant treated stress animals having 
significantly lower insulin levels at all time points. Post hoc analysis revealed that 
rimonabant treated animals had significantly lower basal insulin levels compared to the 
untreated stress animals after 15 hours of food deprivation (p<0.05) and significantly lower 
insulin levels compared to controls (p<0.05) 30 and 90 minutes after the glucose 
administration (figure 25B). 
 
Figure 25: Influence of rimonabant treatment during chronic social stress exposure on long-term changes in 
glucose metabolism at the age of 12 months. Time course of (A) glucose levels during an oral glucose 
tolerance test and (B) corresponding insulin levels. N = 10 per group. * significant from control group, p<0.05 
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Discussion 
In the present study we investigated whether the medium-term effects of chronic social 
stress obtained after at least one week of recovery can be prevented by treatment with the 
potential anxiolytic rimonabant during stress exposure. We chose the CB1 antagonist as it 
is well known that the endogenous cannabinoid system is highly involved in the modulation 
of the HPA axis (Murphy et al., 1998; Patel et al., 2004; Barna et al., 2004) and, although 
many studies have shown rather anxiogenic effects of CB1 antagonism (Navarro et al., 
1997; Arevalo et al., 2001), there is also strong evidence for an anxiolytic capacity of this 
drug (Griebel et al., 2005; Rodgers et al., 2002). However, in our study the compound was 
not able to normalize the medium-term effects of chronic stress exposure on HPA axis 
function and behavior obtained 7-14 days after cessation of the stressor and treatment. 
Rimonabant did not prevent the animals from increased stress hormone levels, nor from 
adrenal enlargement and thymus shrinkage. Moreover, the adrenals of the rimonabant 
treated stress animals were even more enlarged compared to the ones of the untreated stress 
animals. This might be due to the fact, that under chronic treatment with the CB1 
antagonist the dampening effect of the endogenous endocannabinoid system on the HPA 
axis is silenced for a long time and therefore the HPA activity may be even more increased 
in rimonabant treated animals compared to untreated stress animals. Additionally, the fur 
state of the CB1 antagonist treated animals was deteriorated to the same extent as the fur 
state of the untreated chronic stress animals, indicating a reduction in grooming behavior, 
which is associated with a depression-like phenotype (Mineur et al., 2003). Further, 
rimonabant treatment did not affect or avert the stress induced down-regulation of 
hippocampal MR, but it did partly prevent GR down-regulation in the CA1 region and the 
dentate gyrus of the hippocampus. This resembles a similar situation we have observed in 
our model after treatment with the selective CRHR1 antagonist DMP696 during stress 
exposure, where we could also detect a selective prevention of GR down-regulation, with 
no effect on MR expression levels (Schmidt et al., 2007). On the other hand, this is the 
converse effect we observed after treatment with the SSRI paroxetine, where we could 
observe even an increase in MR expression levels with no effect on GR down-regulation, 
suggesting elementary differences in the underlying central pathways involved in their 
mechanism of action (Schmidt et al., 2007). Nevertheless, the rimonabant induced 
prevention of GR down-regulation and the resulting presumably improved negative 
feedback could not counter regulate the largely increased corticosterone levels. In addition, 
rimonabant was not able to reverse the increased anxiety phenotype observed in chronic 
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stress animals 7-14 days after recovery in the elevated plus maze and in the open field test, 
with all three groups displaying similar general locomotor activity. Only in the novelty-
induced suppression of feeding paradigm a slight improvement in terms of shorter feeding 
latencies could be detected. Due to a large standard deviation in all three groups, though, 
this effect was not significant. These findings are in sharp contrast to the data of Griebel 
and colleagues, who could, after chronic rimonabant treatment with the same dose (i.e. 10 
mg/kg per day p.o.) during chronic mild stress, observe both improvement of the fur state 
and a reduction in the stress induced anxiety in the elevated plus maze (Griebel et al., 
2005). However, in this study the animals were tested during the stress phase and under 
treatment, so the alterations in the anxiety-related behavior might be rather attributable to 
the direct effects of the drug than to an efficacious prevention of negative consequences 
originating from the chronic stress paradigm. Another important finding was described by 
Rodgers and colleagues, who reported reduced anxiety-related behavior in the plus maze in 
acutely rimonabant treated animals only in maze experienced and not in maze naïve mice 
and only when treated with a specific dose (i.e. 1 mg/kg i.p.) (Rodgers et al., 2003). As one 
potential interpretation of this pattern the authors suggested that ‘trial 2’ anxiety differs 
qualitatively from ‘trial 1’ anxiety, a hypothesis that is supported by the known ‘one trial 
tolerance’ of several anxiolytics such as diazepam (File and Zangrossi, Jr., 1993; Rodgers 
and Johnson, 1998). Therefore, the initial exposure may fail to recruit, while the different 
experience in ‘trial 2’ might activate the endocannabinoid system, what is an obvious 
prerequisite for the effectiveness of a selective antagonist. Further evidence for this 
hypothesis comes from Marsicano and colleagues who recently reported that re-exposure of 
mice to learned fear cues selectively increase endocannabinoid levels in the basolateral 
amygdala (Marsicano et al., 2002). Therefore it might be possible that in our study existing 
alterations following rimonabant treatment during stress could have been observed in re-
test exposures, but not in single trials. Moreover, as rimonabant was recently found to be 
also able to reduce anxiety-related behavior in CB1 knockout mice (Haller et al., 2002), the 
existence of a second rimonabant sensitive receptor becomes more and more likely. It is 
assumed that CB1 and the potential novel receptor exert opposing effects on anxiety-related 
behavior, with activation of CB1 being anxiolytic and activation of the novel receptor being 
anxiogenic. Thus, in initial trials of anxiety-related tests both receptors might be blocked to 
the same extend thereby neutralizing their effects. Only after desensitization of CB1 
regulated mechanisms in the initial trial, in a second trial predominantly the novel, 
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potentially anxiogenic receptor is blocked, resulting in an anxiolytic-like effect on the 
behavior (Rodgers et al., 2003).  
In conclusion, besides some positive exceptions, like hippocampal GR mRNA expression, 
or negative exceptions, like adrenal enlargement, in our chronic social stress paradigm 
chronic treatment with rimonabant had neither long-term beneficial nor maladaptive effects 
on a physiological, neuroendocrine and behavioral level. 
In the second part of this study we determined the potential long-term consequences of the 
chronic social stress regimen on the animals’ glucose clearance in an oral glucose tolerance 
test and their respective insulin levels at the age of six and 12 months, as we had evidence 
for long-term metabolic changes at an older age resulting from chronic stress from previous 
studies. For instance, via magnet resonance imaging at the age of 15 months, i.e. after one 
year of recovery, we could detect alterations in the fat distribution of the animals with the 
previously stressed ones having an increased ratio of visceral to subcutaneous fat compared 
to controls. These changes could be prevented by chronic treatment with the SSRI 
paroxetine during the stress phase (see project 4). In humans, visceral adiposity is a well 
known risk factor for the development of metabolic syndrome, which is also highly 
associated with changes in insulin sensitivity and diabetes type II. However, in this study 
no differences in glucose nor in insulin levels could be detected between animals of the 
chronic stress and the control group at the age of six or 12 months. A preliminary result 
from pilot studies, where chronic stress animals seemed to have lower insulin levels after 
glucose administration in an equally performed glucose tolerance test, could therefore not 
be corroborated. Hence, alterations in body fat distribution seem therefore not to be 
associated with changes in other metabolic parameters like elevated glucose or insulin 
levels. Further, we investigated whether the chronic rimonabant treatment during the stress 
phase might have a beneficial long-term effect on the animals’ metabolism and is able to 
prevent potential maladaptive consequences. The efficacy of this drug on normalizing body 
weight and metabolic parameters is well established in animals models of obesity: after 
chronic treatment a significant weight loss and reduction in food intake can be observed, 
accompanied by lowered plasma leptin, insulin and fatty acid levels (Ravinet et al., 2003; 
Poirier et al., 2005). The same picture holds true for CB1 knockout mice, which are lighter 
and leaner compared to their wild type controls, accompanied by reduced plasma insulin 
and leptin levels (Ravinet et al., 2004). Recently, also in humans rimonabant was 
introduced as an antiobesity drug (Acomplia®, Sanofi Aventis) leading to improvement of 
lipid and glucose metabolism and an improvement of food intake and energy metabolism 
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(Henness et al., 2006). In our study in both oral glucose tolerance tests, performed at the 
age of six and 12 months respectively, i.e. after three and 9 months of recovery, glucose 
levels did not differ between the groups throughout the test. However, corresponding 
insulin levels were indeed lower in rimonabant treated chronic stress animals compared to 
the control and the untreated chronic stress group at both the age of six months and 12 
months. At both time points the animals of all groups did not differ anymore in their mean 
body weight. Despite their lower insulin levels, the animals of the rimonabant group 
catabolized the glucose at a similar rate compared to the other two groups, suggesting that 
chronic treatment with rimonabant during the adolescent and young adult period of the 
animals had persistently altered the insulin sensitivity of the animals. The mechanisms 
involved are certainly manifold, as the CB1 is ubiquitously expressed in organs involved in 
the regulation of energy homeostasis, such as adipose tissue, muscle, liver and 
gastrointestinal tract (Ameri, 1999). The altered insulin sensitivity might be in part 
attributable to increased adiponectin levels in adipose tissue resulting from CB1 blockade 
as it could be observed in obese fa/fa rats (Bensaid et al., 2003), but also enhanced glucose 
uptake in the muscles and reduced lipogenesis in the liver are likely to play a role (Woods, 
2007). Thus, this is the first study demonstrating long-term beneficial effects of rimonabant 
on insulin sensitivity after a relatively short treatment time (four weeks). In a clinical study, 
Blüher and colleagues demonstrated that circulating endocannabinoids are positively 
correlated with visceral fat mass and fasting plasma insulin concentrations, whereas CB1 
mRNA expression was negatively correlated with visceral fat mass (Blüher et al., 2006). A 
dysregulation of the peripheral endocannabinoid system seems therefore to be associated 
with abdominal fat accumulation and resulting metabolic changes that may finally lead to 
the development of metabolic syndrome. Thus, the endocannabinoid system represents a 
promising target for the treatment of obesity. However, as the CB1 is ubiquitously 
expressed in the CNS and in the periphery, it is currently not possible to target only the 
sites involved in energy homeostasis. Hence, a considerable number of side effects could be 
observed in patients taking rimonabant, among them increased anxiety and depression 
(Henness et al., 2006). Therefore it remains to be seen, if the advantages outweigh the 
potential disadvantages and the subsets of obese patients receiving the drug need to be 
carefully evaluated. 
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7.1 Discussion 
The aim of this thesis was the validation of a novel chronic social stress paradigm in male 
CD1 mice with regard to face, predictive and construct validity (see introduction for 
definition) and to further characterize the resulting long-term consequences on 
neuroendocrine, behavioral and cognitive function as well as alterations in metabolic 
parameters. 
This paradigm shows a high degree of construct validity, mimicking the human situation of 
chronic social stress very closely. The social stress situation is unavoidable for the animals 
and constantly present at every time of the day. Importantly, instead of adapting to the 
situation, the stressfulness of living without clear hierarchical orders seems to increase over 
time. As this paradigm is performed during the adolescent and young adult period, it also 
covers a very important stage of life of the animals and is indeed long enough (seven 
weeks) for effectively resembling a chronic exposure. With our novel animal model, we 
could demonstrate a high degree of face validity for chronic stress, as we found clear and 
robust signs of chronic stress exposure (project 1 and 2). Animals subjected to the chronic 
stress exposure had larger adrenals and a smaller thymus gland, both physiological 
correlates of prolonged activation of the HPA axis. Accordingly, morning corticosterone 
levels where found to be largely increased at the end of the stress period. Interestingly, the 
amount of secreted ACTH was similar between both groups, indicating an enhanced 
adrenal sensitivity in chronic stress animals. We also observed a flattening of the circadian 
rhythm of the animals, a phenomenon which has also been described in depressed patients 
(Deuschle et al., 1997; Weber et al., 2000). The changes in peripheral parameters of the 
HPA axis are paralleled by differences of central gene expression in brain areas involved in 
stress regulation. Most prominently, the expression of mineralocorticoid receptors and 
glucocorticoid receptors in the hippocampus was found to be decreased following chronic 
stress exposure. This finding is in line with previous reports, which also indicated a 
decreased expression of these two receptor subtypes after social stress in tree shrews 
(Meyer et al., 2001). Further, in line with previous evidence we detected an increased 
expression of vasopressin in the paraventricular nucleus, which supports the notion that 
under chronic stress conditions vasopressin plays an increasingly important role in 
regulating HPA axis function (Aguilera, 1994; Volpi et al., 2004).  
Chronic stress exposure also affects the behavior of the animals. Most animal models for 
chronic stress focus on the adverse consequences on the anxiety- and depression like 
phenotype, based on the vast evidence linking stress and affective disorders (Schmidt and 
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Müller, 2006). Predominantly unconditioned anxiety-related behavior seems generally 
increased as a consequence of exposure to chronic stress, thereby supporting 
epidemiological data of an increased risk of anxiety disorders in chronically stressed 
individuals. The data obtained with our model support this hypothesis, as exposure to 
chronic social stress resulted in increased anxiety-like behavior. For instance in the novelty-
induced suppression of feeding test, where the animals are presented with a piece of 
palatable food (e.g. almond) in a novel environment, chronic stress animals spend 
significantly more time until initiating food consumption compared to unstressed controls. 
These data are confirmed by results from the elevated plus maze, where animals subjected 
to chronic stress spend less time on the open, unprotected arms compared to controls, 
indicating increased anxiety. In addition, stressed animals display a significantly 
deteriorated fur quality, indicating a decrease of self care and grooming, which has been 
rather associated with depression-like behavior (Ducottet and Belzung, 2005).  
As pointed out previously, in humans chronic stress is generally not sufficient to induce 
depression, but it is merely one of many possible risk factors. An useful animal model for 
depression should not only include chronic stress as an environmental risk factor, but also 
other environmental or genetic risk factors, which would further enhance the vulnerability 
of the individual. It is thus very important to differentiate between animal models for 
chronic stress and animal models for a specific disease as major depression. While the first 
is readily possible and many good animal models for chronic stress exist, the latter seems 
problematic. 
An important issue that needs to be addressed when considering face validity is the 
persistence of symptoms after chronic stress exposure. The majority of studies investigated 
only effects during or right after the end of the stressor, thereby focusing more on acute 
effects. However, in humans the maladaptive responses to chronic stress often outlast the 
actual stress phase by many years or even decades. Only few preclinical studies examined 
the long-term effects of acute or chronic stressors. Vallès and colleagues investigated the 
long-term consequences of a single immobilization stress on gene expression in several 
brain areas, demonstrating lasting differences in stress-induced gene expression (Valles et 
al., 2003; Valles et al., 2006). Analogously, a single exposure to social defeat stress has 
also been shown to have persistent electrophysiological consequences (Artola et al., 2006). 
Few studies have also indicated that some of the observed neuroendocrine and behavioral 
effects evoked by chronic stressors persist even if the stress is discontinued, which is a 
crucial factor with regard to human pathology (Tsankova et al., 2006). With our new animal 
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model for chronic social stress, we could observe clear effects of the stress exposure days, 
weeks or even months after the termination of the stressor. For instance, certain aspects of 
anxiety-related behavior have still been found altered even 12 months after stress exposure 
(project 2). However, these long-lasting effects are not generalized to all aspects of anxiety, 
but remain defined to specific behavioral domains. Interestingly, the individual variation of 
the persistent and long-term effects of chronic stress exposure is much higher compared to 
the acute and medium-term effects, indicating that some animals had recovered from the 
stressful experience, while others remained affected for a long time. Additionally, at an 
older age also alterations in the cognitive function of previously stressed animals (project 3) 
could be detected. These are manifested in an inferior performance in spatial memory tests 
compared to controls paralleled by reduced in vitro LTP. Also metabolic parameters like 
body fat distribution were found altered several months after cessation of the stressor 
(project 4) implying a long-lasting high impact of the stress regimen on the metabolism of 
the animals. 
The third main validity criterion for animal models is the predictive validity. With our 
model, we could demonstrate that many of the persistent effects of chronic stress exposure 
can be prevented by simultaneous pharmacological treatment with different types of 
antidepressants: the serotonin reuptake inhibitor paroxetine (project 1 and 3) and the novel 
non-peptide CRH-receptor 1 antagonist DMP696 (project 1). Although both drugs were 
effective in preventing or ameliorating the stress effects, the mechanism of action 
underlying is probably very different. Especially for the CRHR1 antagonist it seems likely 
that the treatment effects are based on a specific suppression of the CRH-mediated effects 
of stress exposure in the brain and the periphery. On the contrary, treatment with the 
potentially anxiolytic CB1 antagonist rimonabant did not improve stress symptoms (project 
5). However, more drugs and compounds from different classes of drugs need to be tested 
in this model before the claim of good predictive validity could be fully made. Further, as 
we observed clear long-lasting effects of the chronic stress exposure, a treatment starting 
after the termination of the stress paradigm would probably resemble the human situation 
more closely. 
Taken together, the recently developed chronic social stress paradigm in mice provides a 
useful basis to further elucidate the neurobiological mechanisms underlying the postulated 
causal relationship between chronic stress and the development of human affective 
disorders. A better understanding of those pathophysiological mechanisms, in turn, will 
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contribute to the development of novel, innovative drugs in the future, especially in the 
field of antidepressants. 
 
7.2 Conclusions 
The following conclusions may be drawn from the results presented in this thesis: 
 
(1) The chronic social stress paradigm is a valid animal model for investigating 
symptoms of stress-related disorders  
(2) The chronic stress regimen evoked severe and long lasting changes on a 
physiological, neuroendocrine and behavioral level 
(3) The chronic stress experience had influence on cognitive function in aged animals 
(4) Chronic stress during adolescence is a risk factor for metabolic alterations later in 
life 
(5) Rimonabant can not be utilized as an anxiolytic or antidepressant drug in this 
paradigm  
 
7.3 Future perspectives 
A main advantage of this novel animal model for chronic stress compared to other rodent 
models is the possibility to conduct large-scale studies, where a high number of animals can 
be stressed simultaneously. A rate limiting factor is now the throughput of tests or 
measurements (behavior, physiology etc.), rather than the availability of stressed and 
control mice. By using this model in large-scale approaches, it is thus now possible to study 
the issue of individual vulnerability to chronic stress by comparing the individual responses 
(acute and long-term) within the chronic stress group and to detect new potential target 
genes that are involved either in the process of recovery or in the maintenance of prolonged 
stress symptoms. It seems clear that in order to mimic the human situation of chronic stress 
exposure and the consequent increased risk for diseases in animals, it is necessary to 
incorporate the issue of stress vulnerability. A better understanding of why a certain 
combination of genetic and environmental risk factors together with individual life history 
leads to a specific disease is essential for the study of successful treatment strategies. Future 
research will therefore have to focus more on the individual differences in being resistant to 
stressful situations. The development of a novel mouse paradigm for chronic stress, which 
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offers the possibility to work with a high number of animals, is thus a first step in this 
direction and will open up new research possibilities.  
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Summary 
Besides genetic risk factors, increasing evidence shows an important role of environmental 
factors as stressful life events for the development of metabolic, cardiovascular and 
affective disorders. Particularly chronic stress and the resulting characteristic dysregulation 
of the hypothalamic-pituitary-adrenocortical (HPA) axis are regarded as key risk factors for 
a variety of diseases, including major depression and anxiety disorders. As experimental 
variation of early environment and stress exposure cannot be performed in humans for 
ethical reasons, preclinical studies using animal models are indispensable to improve our 
understanding of the consequences of chronic stress.  
A large number of paradigms have been established to induce chronic stress in rodents. 
However, many of these paradigms do not consider the etiology of human stress-associated 
disorders, where the stressors involved are mostly of a social nature and the effects of the 
stress exposure persist, even if the stressor is discontinued. In addition, many chronic stress 
paradigms are problematic with regard to stress adaptation, continuity, duration and 
applicability. 
To overcome these limitations, this doctoral thesis develops and evaluates a novel chronic 
social stress paradigm in male CD1 mice, which is based on a chronically unstable social 
environment. As many psychiatric studies indicate that childhood and adolescence are 
periods of high stress and trauma vulnerability, the animals are exposed to the stressor 
during their adolescent and young adult period. This chronic social stress regimen lasts 
continuously for seven weeks and results in long-term physiological, neuroendocrine and 
behavioral changes. It fulfills the criteria of face, construct and predictive validity for 
animals models of chronic stress, thereby mimicking the human condition of stress-related 
disorders with respect to its etiology, symptomatology, treatment and behavioral basis. The 
model is further suitable to investigate the interaction between genetic susceptibility and 
environmental factors. 
Part I introduces the topic by describing the function of the stress system and its 
components, with CRH being one of the key regulators of the stress response, orchestrating 
neuroendocrine, autonomic and immune processes in response to stress. After that, the 
chapter approaches the function of MR and GR in the negative feedback regulation of the 
HPA axis. Further, chronic stress is described as a risk factor for a variety of diseases, and 
several existing animals models for chronic stress are summarized. Also the key issue of 
individual vulnerability is discussed briefly. Finally, the objectives of the thesis are 
formulated, with a primary focus on the validation of the novel animal model. Furthermore, 
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the resulting long-term consequences on neuroendocrine, behavioral and cognitive function, 
as well as on metabolic parameters, are to be characterized. 
In project 1 the physiological, neuroendocrine and behavioral alterations obtained 7-14 
days after cessation of the stress regimen, i.e. after 7-14 days of recovery, are described. 
Animals subjected to the chronic stress exposure displayed severe signs of stress in terms of 
increased corticosterone levels, increased adrenal and decreased thymus weights and a 
down-regulation of mineralocorticoid receptor (MR) and glucocorticoid receptor (GR) 
mRNA levels. Also anxiety-related behavior in the elevated plus maze, the open field and 
the novelty-induced suppression of feeding paradigm was affected. Most consequences 
evoked by the chronic social stress regimen could be prevented by simultaneous, chronic 
treatment, with either the selective serotonin reuptake inhibitor (SSRI) paroxetine or the 
corticotropin releasing hormone receptor 1 antagonist DMP696. Corticosterone levels and 
organ weights were comparable to control ones and also the phenotype observed in chronic 
stress animals in the open field and in the novelty-induced suppression of feeding test could 
be reversed. By determination of hippocampal MR and GR mRNA expression levels, the 
different underlying mechanisms of action became apparent: paroxetine treatment mainly 
affected MR expression, while DMP696 selectively prevented GR down-regulation. 
In project 2 the investigation of the persistent effects of chronic stress is continued by 
extending the recovery phase to 12 months. Physiological, neuroendocrine and behavioral 
parameters were assessed one year after stress termination and summarized in comparison 
to the immediate effects obtained shortly after cessation of the stressor. Although the 
changes of many parameters were far more pronounced when assessed immediately at the 
end of the stress phase, even one year after termination of the stressor significant 
differences between the previously stressed animals and their respective controls could be 
detected. For instance, MR was still found down-regulated in the CA3 region and in the 
dentate gyrus of the hippocampus, suggesting a persistent change in gene expression 
profile. Additionally, animals of the chronic stress group still displayed a more anxious 
phenotype in the elevated plus maze and the open field test. However, individual variation 
of the persisting effects was much higher compared to the results observed immediately or 
7-14 days after stress termination, indicating that some animals had recovered from the 
stress experience, while others remained affected throughout their life span. 
In project 3 we have focused our attention on the impact of the chronic stress phase during 
adolescence on the cognitive function of the animals at an old age, as we had detected 
persistent alterations in MR expression, which is known to be involved in information 
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processing. One year after cessation of the stressor, animals of the chronic stress group 
performed significantly worse in the Y-maze and the Morris water maze tests, both 
investigating spatial memory. In the object recognition and social discrimination test, no 
differences could be detected. The deficits in the spatial memory were paralleled by 
reduced in vitro LTP, measured in the Schaffer collateral pathway of the hippocampal CA1 
region. Furthermore, the mRNA expression levels of the neurotrophic factor BDNF were 
found to be decreased in the hippocampus and the cortex. Those pronounced differences in 
BDNF expression suggest that structural parameters underlying the functional deficits in 
previously stressed animals might contribute to the weaker LTP. Additionally, expression 
levels of several neurotransmitter receptor subunits, which are known to play a key role in 
hippocampal learning and memory, such as GABA A and AMPA 1, were altered, certainly 
also contributing to the impaired memory function. 
Chronic stress is also known to be a risk factor for metabolic diseases. In project 4 we 
therefore assessed potential metabolic alterations resulting from the chronic stress 
experience in animals at an older age. Therefore the body fat distribution of subcutaneous 
and visceral fat was determined via functional magnet resonance imaging (FMRI) in 15-
month- old mice. An increased ratio of visceral to subcutaneous fat could be detected in 
previously stressed animals with no differences in body weight compared to controls. 
Interestingly, also these metabolic alterations could be prevented by antidepressant 
treatment with paroxetine, applied during the stress phase. 
To study the crucial link between affective disorders and metabolic diseases, in project 5 
the connection between the cannabinoid system and the stress system was further 
examined. Therefore, the efficacy of chronic treatment with the selective cannabinoid 
receptor 1 (CB1) antagonist rimonabant during the chronic stress period to prevent 
physiological, neuroendocrine and behavioral alterations observed in untreated stress 
animals was assessed. 7-14 days after cessation of the stress regimen, i.e. after 7-14 days of 
recovery, thymus weight of rimonabant-treated animals was diminished and their adrenals 
were found to be even more enlarged compared to untreated stress animals and controls. 
Also corticosterone levels were highly increased, and hippocampal MR mRNA down-
regulation could not be averted. Only GR mRNA down-regulation in the CA1 region and 
the dentate gyrus of the hippocampus was partly prevented. In addition, rimonabant was not 
able to reverse the increased anxiety phenotype observed in chronic stress in the elevated 
plus maze and in the open field test. In the novelty-induced suppression of feeding 
paradigm a slight improvement in terms of shorter feeding latencies could be detected. 
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Taken together, in our paradigm rimonabant treatment during the stress phase was not very 
efficacious in preventing or reversing stress symptoms on the above mentioned levels. To 
further characterize potential changes in metabolic parameters, the animals were subjected 
to an oral glucose tolerance test at an older age, and their glucose and corresponding insulin 
levels were measured. However, contrary to preliminary results from pilot studies, no 
differences in glucose nor in insulin levels could be detected between animals of the 
chronic stress and the control group at the age of six and 12 months. However, in the 
previously rimonabant treated animals, insulin levels were indeed lower, compared to the 
controls and the untreated chronic animals with no differences between the groups in 
corresponding glucose levels. This may indicate that chronic treatment with rimonabant 
during the adolescent and young adult period of the animals had persistently altered the 
insulin sensitivity of the animals. 
Part IV summarizes and discusses the results of this thesis in its entirety. It is concluded 
that the chronic social stress paradigm is a valid animal model for investigating symptoms 
of stress-related disorders with regard to face, predictive and construct validity. The chronic 
stress regimen evoked severe and long lasting changes on a physiological, neuroendocrine 
and behavioral level and further affected cognitive function and metabolic parameters of 
the animals at an older age.  
With respect to the postulated causal relationship between chronic stress and the 
development of various human diseases, including affective disorders, these data establish 
the basis to study the underlying neurobiological mechanisms in more detail. A better 
understanding of those pathophysiological mechanisms, in turn, will contribute to the 
development of novel, innovative antidepressant drugs in the future. In order to mimic the 
human situation of chronic stress exposure and the consequent increased risk for diseases in 
animals more closely, it is now possible and necessary to incorporate the issue of individual 
stress vulnerability by comparing the individual responses (acute and long-term) within the 
chronic stress group by using this model in large-scale approaches. 
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List of abbreviations 
ACTH  adrenocorticotropic hormone  
AMPA R ionotropic glutamate receptor with α-amino-3-hydroxy-5-methylisoxazole-4-  
  propionic acid as its synthetic agonist 
ANOVA analysis of variance 
AP-1   activating protein 1 
AVP  arginine vasopressin 
BDNF  brain derived neurotrophic factor 
BSA  bovine serum albumine 
CA  cornu ammonis (part of the hippocampal formation) 
CB1  cannabinoid receptor 1 
CMS  chronic mild stress 
CNS  central nervous system 
CREB  cAMP response element binding protein 
CRH  corticotropin releasing hormone 
CRHR  corticotropin releasing hormone receptor 
DG  dentate gyrus 
FMRI  functional magnet resonance imaging 
GABAR class of receptors that respond to gamma amino butyric acid 
GR  glucocorticoid receptor 
GRE  glucocorticoid response element 
HPA axis  hypothalamo pituitary adrenal axis 
i.p.  intraperitoneal 
ITI  intertrial interval 
LTP  long-term potentiation 
MR  mineralocorticoid receptor 
NFκB  neurotrophic factor kappa B 
NMDA N-Methyl-D-Aspartat  
NR NMDA-type ionotropic glutamate receptor with N-Methyl-D-Aspartat as its 
specific agonist; NRs are heteromers consisting of the subunits NR1 and 
various subunits of NR2, with the subunits NR2A and NR2B being the most 
important subunits 
p.o. per oral 
POMC  preopiomelanocortin 
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PVN  paraventricular nucleus of the hypothalamus 
SEM  standard error of the mean 
SDS-PAGE sodium dodecylsulfate polyacrylamide gel electrophoresis 
V1b  vasopressin receptor 1b 
11β HSD-1 11β hydroxysteroid dehydrogenase type 1  
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